0001662252-23-000017.txt : 20230515 0001662252-23-000017.hdr.sgml : 20230515 20230515143921 ACCESSION NUMBER: 0001662252-23-000017 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 46 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Regenicin, Inc. CENTRAL INDEX KEY: 0001412659 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: WY FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-146834 FILM NUMBER: 23921059 BUSINESS ADDRESS: STREET 1: 10 HIGH COURT CITY: LITTLE FALLS STATE: NJ ZIP: 07424 BUSINESS PHONE: (973) 557-8914 MAIL ADDRESS: STREET 1: 10 HIGH COURT CITY: LITTLE FALLS STATE: NJ ZIP: 07424 FORMER COMPANY: FORMER CONFORMED NAME: Windstar Inc. DATE OF NAME CHANGE: 20070918 10-Q 1 rgin10q.htm 10-Q
0001412659 Q1 --09-30 2023 false 0001412659 2022-10-01 2023-03-31 0001412659 2023-04-04 0001412659 2023-03-31 0001412659 2022-09-30 0001412659 2021-10-01 2022-03-31 0001412659 2023-01-01 2023-03-31 0001412659 2022-01-01 2022-03-31 0001412659 us-gaap:PreferredStockMember 2022-09-30 0001412659 us-gaap:CommonStockMember 2022-09-30 0001412659 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001412659 us-gaap:RetainedEarningsMember 2022-09-30 0001412659 us-gaap:TreasuryStockCommonMember 2022-09-30 0001412659 us-gaap:PreferredStockMember 2022-12-31 0001412659 us-gaap:CommonStockMember 2022-12-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001412659 us-gaap:RetainedEarningsMember 2022-12-31 0001412659 us-gaap:TreasuryStockCommonMember 2022-12-31 0001412659 2022-12-31 0001412659 us-gaap:PreferredStockMember 2021-09-30 0001412659 us-gaap:CommonStockMember 2021-09-30 0001412659 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001412659 us-gaap:RetainedEarningsMember 2021-09-30 0001412659 us-gaap:TreasuryStockCommonMember 2021-09-30 0001412659 2021-09-30 0001412659 us-gaap:PreferredStockMember 2021-12-31 0001412659 us-gaap:CommonStockMember 2021-12-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001412659 us-gaap:RetainedEarningsMember 2021-12-31 0001412659 us-gaap:TreasuryStockCommonMember 2021-12-31 0001412659 2021-12-31 0001412659 us-gaap:PreferredStockMember 2022-10-01 2022-12-31 0001412659 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001412659 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001412659 us-gaap:TreasuryStockCommonMember 2022-10-01 2022-12-31 0001412659 2022-10-01 2022-12-31 0001412659 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001412659 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001412659 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001412659 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001412659 us-gaap:PreferredStockMember 2021-10-01 2021-12-31 0001412659 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001412659 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001412659 us-gaap:TreasuryStockCommonMember 2021-10-01 2021-12-31 0001412659 2021-10-01 2021-12-31 0001412659 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001412659 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001412659 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001412659 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0001412659 us-gaap:PreferredStockMember 2023-03-31 0001412659 us-gaap:CommonStockMember 2023-03-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001412659 us-gaap:RetainedEarningsMember 2023-03-31 0001412659 us-gaap:TreasuryStockCommonMember 2023-03-31 0001412659 us-gaap:PreferredStockMember 2022-03-31 0001412659 us-gaap:CommonStockMember 2022-03-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001412659 us-gaap:RetainedEarningsMember 2022-03-31 0001412659 us-gaap:TreasuryStockCommonMember 2022-03-31 0001412659 2022-03-31 0001412659 RGIN:AMBSMember 2023-03-31 0001412659 srt:ChiefFinancialOfficerMember 2020-03-31 0001412659 srt:ChiefFinancialOfficerMember 2022-10-01 2022-12-31 0001412659 srt:ChiefFinancialOfficerMember 2022-10-01 2023-03-31 0001412659 srt:ChiefFinancialOfficerMember 2021-10-01 2022-03-31 0001412659 srt:ChiefFinancialOfficerMember 2023-01-01 2023-03-31 0001412659 srt:ChiefFinancialOfficerMember 2022-01-01 2022-03-31 0001412659 srt:ChiefFinancialOfficerMember 2023-03-31 0001412659 srt:ChiefFinancialOfficerMember 2022-09-30 0001412659 RGIN:ChiefScienceOfficerMember 2020-09-30 0001412659 srt:ChiefExecutiveOfficerMember 2018-09-30 0001412659 srt:ChiefFinancialOfficerMember 2020-07-01 2022-09-30 0001412659 srt:ChiefFinancialOfficerMember 2022-09-30 0001412659 RGIN:PromissoryNote2Member 2022-10-01 2023-03-31 0001412659 RGIN:PromissoryNote2Member 2023-03-31 0001412659 RGIN:PromissoryNote2Member 2022-09-30 0001412659 RGIN:PromissoryNote2Member 2021-10-01 2022-03-31 0001412659 RGIN:AmtorizedCostsMember 2023-03-31 0001412659 RGIN:UnrealizedLossMember 2023-03-31 0001412659 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-03-31 0001412659 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-09-30 0001412659 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  For the quarterly period ended March 31, 2023
   
☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934
  For the transition period from                  to __________
   
 

Commission File Number: 333-146834 

 

Regenicin, Inc.
(Exact name of registrant as specified in its charter)

 

Wyoming 27-3083341
(State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.)

 

OTCBB RGIN COMMON
Principal US Market Symbol Class of Trading Security

 

10 High Court, Little Falls, NJ 07424 (973) 557-8914
(Address of principal executive offices) (Registrant’s telephone number)

_______________________________________________________________
(Former name, former address and former fiscal year, if changed since last report)

   

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐Yes ☒No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☐Yes ☒No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.

 

Large accelerated filer ☐ Non-accelerated Filer ☐
Non-accelerated filer ☐ Smaller reporting company ☒
    Emerging growth company ☐

  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐Yes ☒No

 

State the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 153,483,050 as of April 4, 2023.

 

NOTICE: THIS 10Q FILING DOES NOT CONTAIN FINANCIAL OR OTHER INFORMATION WHICH HAS BEEN AUDITED OR REVIEWED BY OUR INDEPENDENT PUBLIC ACCOUNTING FIRM FOR REASONS SPECIFIED HEREIN. WE INTEND TO SUPPLEMENT THIS FILING, AT A CURRENTLY UNKNOWN LATER DATE, WITH SUCH REVIEWED AND AUDITED FINANCIAL INFORMATION, IF AND WHEN SUCH REVIEW AND AUDIT CAN BE OBTAINED. 

 

   

 

  TABLE OF CONTENTS Page 
 
PART I – FINANCIAL INFORMATION
 
Item 1: Financial Statements 3
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations 4
Item 3: Quantitative and Qualitative Disclosures About Market Risk 7
Item 4: Controls and Procedures 7
PART II – OTHER INFORMATION
Item 1: Legal Proceedings 8
Item 1A: Risk Factors 8
Item 2: Unregistered Sales of Equity Securities and Use of Proceeds 8
Item 3: Defaults Upon Senior Securities 8
Item 4: Mine Safety Disclosures 8
Item 5: Other Information 8
Item 6: Exhibits 8

 

 2 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements 

 

Our consolidated financial statements included in this Form 10-Q are as follows: 

 

The consolidated financial statements for the six months ended March 31, 2023 and 2022 have not been reviewed by our independent registered public accounting firm. The consolidated balance sheet as September 30, 2022 has not been audited by our independent registered public accounting firm. 

 

F-1 Consolidated Balance Sheets as of March 31, 2023 (unreviewed) and September 30, 2022 (unaudited);
F-2 Consolidated Statements of Operations for the three and six months ended March 31, 2023 and 2022 (unreviewed);
F-3 Consolidated Statements of Stockholders’ Deficiency for the six months ended March 31, 2023 and 2022 (unreviewed);
F-4 Consolidated Statements of Cash Flows for the six months ended March 31, 2023 and 2022 (unreviewed); and
F-5 Notes to Consolidated Financial Statements.

 

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the SEC instructions to Form 10-Q. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period ended March 31, 2023 are not necessarily indicative of the results that can be expected for the full year.

 

 3 

REGENICIN, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

(UNREVIEWED AND UNAUDITED)

 

  March 31,
2023		  September 30,
2022
   (Unreviewed)    (Unaudited) 
ASSETS         
CURRENT ASSETS         
Cash $10,880,109   $14,568 
Investment, at amortized cost  978,860    —  
Common stock of Amarantus  225    925 
Total current and total assets $11,859,194   $15,493 
LIABILITIES AND STOCKHOLDERS' DEFICIENCY         
CURRENT LIABILITIES         
Accounts payable $—    $103,119 
Accrued expenses - other (related party of $75,389 and $65,471)  281,739    254,595 
Accrued salaries - officers  4,612,001    4,612,001 
Deferred income  12,533,625    —   
Promissory note payable  175,000    175,000 
Convertible promissory note - officer  335,683    335,683 
Loan payable  10,000    10,000 
Loans payable - officer  122,235    122,235 
Total current liabilities $ 18,070,283   $ 5,612,633 
STOCKHOLDERS' DEFICIENCY         
Series A 8% Convertible Preferred stock, $0.001 par value, 5,500,000 shares authorized; 885,000 issued and outstanding  885    885 
Common stock, $0.001 par value; 200,000,000 shares authorized; 157,911,410 issued and 153,483,050 outstanding  157,914    157,914 
Additional paid-in capital  10,208,339    10,208,339 
Accumulated deficit  (16,573,799)   (15,959,850)
Less: treasury stock; 4,428,360 shares at par  (4,428)   (4,428)
Total stockholders' deficiency  (6,211,089)   (5,597,140)
Total liabilities and stockholders' deficiency $11,859,194   $15,493 

 

See Notes to Consolidated Financial Statements.

 F-4 

REGElNICIN, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNREVIEWED)

 

  Six Months Ended
March 31, 2023		  Six Months Ended
March 31, 2022		  Three Months Ended
March 31, 2023		  Three Months Ended
March 31, 2022
            
Revenues $—     $—     $—     $—   
Operating expenses                   
Research and development  432,256    —     94,743    — 
General and administrative  163,199    302,045    233,093    155,513 
Total operating expenses  595,455    302,045    327,836    155,513 
Operating loss before other operating income  (595,455)   (302,045)   (327,836)   (155,513)
Other operating income - reversal of accounts payable  —      —      —      —   
Other income (expenses)                   
Interest expense (related party of $9,918, $9,132, $4,984 and $4,600)  (18,644)   (17,954)   (9,249)   (9,011)
Interest income on held-to-maturity investment  850    —     850    —  
Change in unrealized gain (loss) on securities  (700)   (775)    (200)   (2,125) 
Total other expenses  (18,494)   (18,729)   (8,599)   (11,136)
Net loss  (613,949)   (320,774)   (336,435)   (166,649)
Preferred stock dividends  (35,303)   (35,303)   (17,458)   (17,458)
Net loss attributable to common stockholders $(649,252)  $(356,077)  $(353,893)  $(184,107)
Loss per share basic $(0.00)  $(0.00)  $(0.00)  $(0.00)
Loss per share diluted $(0.00)  $(0.00)  $(0.00)  $(0.00)
Weighted average number of shares outstanding basic  153,483,050    153,483,050    153,483,050    153,483,050 
Weighted average number of shares outstanding diluted  153,483,050    153,483,050    153,483,050    153,483,050 

 

See Notes to Consolidated Financial Statements.

 F-5 

REGENICIN, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIENCY
(UNREVIEWED)

                         
              Additional          
  Convertible Preferred Stock  Common Stock  Paid-in  Accumulated   Treasury   
  Shares  Amount  Shares  Amount  Capital  Deficit   Stock (1)  Total
                         
Balances at October 1, 2022  885,000   $885    157,911,410   $157,914   $10,208,339   $(15,959,850)   $(4,428)   (5,597,140)
Net Loss  —    —    —    —    —   (277,514)     —    (277,514)
Balances at December 31, 2022  885,000    885    157,911,410    157,914    10,208,339    (16,297,135)    (4,428)   (5,934,425)
Net Loss  —    —    —    —    —    (336,435)    —    (336,435)
Balances at March 31, 2023  885,000   $885    157,911,410   $157,914   $10,208,339   $(16,574,649)   $(4,428)   (6,211,939)
Balances at October 1, 2021  885,000    885    157,911,410    157,914    10,208,339    (15,320,588)    (4,428)   (4,957,878)
Net Loss  —    —    —    —    —    (154,125)    —    (154,125)
Balances at December 31, 2021  885,000   885    157,911,410   157,914   10,208,339   (15,474,713)   (4,428)  (5,112,003)
Net Loss  —    —    —    —    —    (166,649)    —    (166,649)
Balances at March 31, 2022  885,000   $885    157,911,410   $157,914   $10,208,339   $(15,641,362)   $(4,428)  $(5,278,652)

 

(1)The number of shares in treasury stock for all periods presented was 4,428,360.

 

See Notes to Consolidated Financial Statements. 

 F-6 

REGENICIN, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNREVIEWED)

 

Six Months Ended
March 31,		  Six Months Ended
March 31,
  2023  2022
 
CASH FLOWS FROM OPERATING ACTIVITIES         
Net loss $(613,949)  $(320,774)
Adjustments to reconcile net loss to net cash used in operating activities:         
Unrealized loss on investment  700   775 
Accrued interest on loans and notes payable  18,644    17,954 
Accretion of discount on held-to-maturity investment  (850)    —   
Changes in operating assets and liabilities         
Accounts payable  (103,119)    (8,676)
Accrued expenses - other  8,500    3,075 
Accrued salaries - officers  —      290,500 
Net cash used in operating activities  (690,074)   (17,146)
CASH FLOWS FROM INVESTING ACTIVITIES         
Proceeds of loans from officers  —      17,000 
Proceeds from the sale of partnership interests  (978,010)   —   
Net cash provided by financing activities  (978,010)    17,000 
NET INCREASE IN CASH  10,865,541    (146) 
CASH - BEGINNING OF PERIOD  14,568    1,859 
CASH - END OF PERIOD $10,880,109   $1,713 
Supplemental disclosures of cash flow information:         
Cash paid for interest $—     $—   
Cash paid for taxes $—     $—   

 

See Notes to Consolidated Financial Statements.

 F-7 

REGENICIN, INC. AND SUBSIDIARY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(UNREVIEWED)

 

NOTE 1 - THE COMPANY

 

Regenicin, Inc. ("Regenicin"), formerly known as Windstar, Inc., was incorporated in the state of Nevada on September 6, 2007. On July 19, 2010, the Company amended its Articles of Incorporation to change the name of the Company to Regenicin, Inc. On August 31, 2022, we filed articles of continuance with the states of Nevada and Wyoming effectively moving our organizational jurisdiction from Nevada to Wyoming effective on that date. The Company's business plan is to develop and commercialize a potentially lifesaving technology by the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a variety of plastic surgery procedures.

 

In October 2022, the Company set up a new Nevada Series LLC called NovaDerm Product Package, LLC (“NPP LLC”). During November and December 2022, consistent with Nevada law governing this Master Series LLC, the Company established twenty-five (25) individual series LLCs, identifying each with a series letter of A through T or AA through EE. Thus, each of these sub-entities were named NovaDerm Product Package Series A, LLC through Series T, LLC, and then Series AA to Series EE, LLC (or NPP-A through NPP-T and NPP-AA through NPP-EE for short).

 

Into each of these twenty-five individual Series LLCs, the Company contributed the right and exclusive ownership to a certain amount of the bovine hides and corium that the Company currently owned and used as key materials in the preparation of its NovaDerm® product, as well as the right to designate: (a) the specific patient cultured skin to be prepared from these materials; (b) the amount of this cultured skin to be prepared up to a designated amount and (c) the medical facility to receive the fully prepared and processed NovaDerm® cultured skin from these materials (these materials and combined designation rights are collectively referred to herein as the “NovaDerm® Product Rights”). For NPP-A through NPP-T and NPP-AA through NPP-CC the Company designated 33,333 cm2 of these NovaDerm® Product Rights. For NPP-DD they designated 30,625 cm2 of NovaDerm® Product Rights and for NPP-EE they designated 28,783 cm2 of NovaDerm® Product Rights. Each contribution of each of the NovaDerm® Product Rights was provided in exchange for 100 membership interests in the Series LLC which represented 100% of all membership interests issued.

 

The Company subsequently transferred 99% of their membership interests (or 99 membership interests) in each of these Series LLC to various Limited Liability Companies, held by individuals unknown to us, in exchange for a pre-agreed payment. Prior to December 31, 2022, the members of these LLCs voted to donate 100% of the membership interests to charity.

 

While the Company retains possession of the materials transferred in each Series LLC contribution, the Company has a continuing obligation to segregate and manage those materials as well as to prepare the NovaDerm® cultured skin product as designated by each Series LLC holder or their designate. The identified materials are currently set apart from other such materials and are being held by the Company pending the identification of the patient and medical facility as instructed by each NovaDerm® Product Rights holder. Notwithstanding this retention of possession by the Company, the ownership and legal title to the materials are retained and fully vested in the individual Series LLC or its designate.

 

The above-described transfers of membership interests in the Series LLCs generated a substantial amount of cash which we are obligated to use for the completion of our NovaDerm IND and the administration of our product clinical trials. No assurance, however, can be given as to the success or failure of such IND or clinical trials, or as to any future FDA decisions made following these trials. Due to the continuing obligation the Company recorded the amount received as deferred income.

 

 F-8 

 

NOTE 2 - BASIS OF PRESENTATION

 

Interim Financial Statements:

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and note disclosures required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of those of a recurring nature) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023, are not necessarily indicative of the results that may be expected for the year ending September 30, 2023. These unaudited consolidated financial statements should be read in conjunction with the unaudited consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2022, as filed with the Securities and Exchange Commission. The consolidated balance sheet as of September 30, 2022, contained herein has been derived from the unaudited consolidated financial statements as of September 30, 2022, but does not include all disclosures required by U.S. GAAP.

 

Going Concern:

 

The Company's consolidated financial statements have been prepared assuming that the Company will continue as a going concern which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses and as of March 31, 2023, has an accumulated deficit of approximately $16.6 million from inception, expects to incur further losses in the development of its business and has been dependent on funding operations through the issuance of convertible debt, private sale of equity securities, and recently the certain partnership interest. These conditions raise substantial doubt about the Company's ability to continue as a going concern. Currently management plans to finance operations through the private or public placement of debt and/or equity securities. However, no assurance can be given at this time as to whether the Company will be able to obtain such financing. The consolidated financial statements do not include any adjustment relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Financial Instruments and Fair Value Measurement:

 

As of October 1, 2018, the Company adopted ASU No. 2016-01, “Financial Instruments-Overall: Recognition and Measurement of Financial Assets and Financial Liabilities”. The new standard principally affects accounting standards for equity investments, financial liabilities where the fair value option has been elected, and the presentation and disclosure requirements for financial instruments. Upon the effective date of the new standards, all equity investments in unconsolidated entities, other than those accounted for using the equity method of accounting, will generally be measured at fair value through earnings. There no longer is an available-for-sale classification and therefore, no changes in fair value will be reported in other comprehensive income (loss) for equity securities with readily determinable fair values. As a result of the adoption, the Company recorded a cumulative effect adjustment of a $950 decrease to accumulated other comprehensive income, and a corresponding decrease to accumulated deficit, as of October 1, 2018.

 

Common stock of Amarantus BioScience Holdings, Inc. (“Amarantus”) is carried at fair value in the accompanying consolidated balance sheets. Fair value is determined under the guidelines of GAAP which defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Realized gains and losses, determined using the first-in, first-out (FIFO) method, and unrealized gains and losses are included in other income (expense) on the statement of operations.

 

The common stock of Amarantus is valued at the closing price reported on the active market on which the security is traded. This valuation methodology is considered to be using Level 1 inputs. The total value of Amarantus common stock at March 31, 2023 is $225. The change in unrealized loss for the six months ended March 31, 2023 and 2022 was $(700) and $(775) net of income taxes, respectively, and was reported as other income (expense).

 

Recently Issued Accounting Pronouncements:

 

Any recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the consolidated financial statements of the Company.

 

 F-9 

 

NOTE 3 - LOSS PER SHARE

 

Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share gives effect to dilutive convertible securities, options, warrants and other potential common stock outstanding during the period; only in periods in which such effect is dilutive.

 

The following weighted average securities have been excluded from the calculation of net loss per share for the six months ended March 31, 2023 and 2022 as the exercise price was greater than the average market price of the common shares:

 

  2023   2022  
Options   11,771,344        11,771,334     

 

The following weighted average securities have been excluded from the calculation because the effect of including these potential shares was anti-dilutive due to the net losses incurred during the six months ended March 31, 2023 and 2022:

 

  2023  2022
Convertible Preferred Stock  8,850,000    8,850,000 
Convertible Promissory Note  99,889,073    19,072,770 
 108,739,073    36,694,114 

 

NOTE 4 – LOANS PAYABLE

 

Convertible Promissory Note – Officer

 

Through March 31, 2020, John Weber, the Company's Chief Financial Officer, advanced the Company a total of $335,683. On March 31, 2020, these advances were converted into a convertible promissory note. Interest on the note is computed at 5% per annum and accrues from the time of the advances until the maturity date. The original maturity date was September 30, 2020, at which time all the accrued interest and principal became due. The note has been extended several times and most recently to December 31, 2022. For the six and three months ended March 31, 2023 and 2022 interest totaling $9,918, $9,132, $4,984 and $4,600, respectively, was incurred. Accrued interest on the note was $75,389 and $65,471 at March 31, 2023 and September 30, 2022, respectively, which is included in accrued expenses on the accompanying consolidated balance sheets. The note is convertible at the option of Mr. Weber into shares of the Company's common stock at the prevailing market rate on the date of conversion.

 

Loan Payable:

 

In February 2011, an investor advanced $10,000. The loan does not bear interest and is due on demand. At both March 31, 2023 and September 30, 2022, the loan payable totaled $10,000.

 

Loans Payable - Officer:

 

Through September 30, 2020, J. Roy Nelson, the Company’s Chief Science Officer, made net advances to the Company totaling $26,935. The loans do not bear interest and are due on demand.

 

In September 2018, Randall McCoy, the Company’s Chief Executive Officer, advanced to the Company $4,500. The loan does not bear interest and is due on demand.

 

From July 2020 through September 2022, John Weber, the Company’s Chief Financial Officer, advanced to the Company $90,800. The loan bears interest at 5% per annum and is due on demand.

 F-10 

 

NOTE 5 - BRIDGE FINANCING

 

On December 21, 2011, the Company issued a $150,000 promissory note to an individual. The note bore interest so that the Company would repay $175,000 on the maturity date of June 21, 2012. Additional interest of 10% was charged on any late payments. The note was not paid at the maturity date and the Company is incurring additional interest as described above. At both March 31, 2023 and September 30, 2022, the note balance was $175,000. Interest expense was $8,726 for each of the six months ended March 31, 2023 and 2022. Accrued interest on the note was $186,664 and $179,938 as of March 31, 2023 and September 30, 2022, respectively, and is included in Accrued expenses - other in the accompanying consolidated balance sheets.

 

NOTE 6 - INVESTMENTS

 

The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such determinations at each consolidated balance sheet date. Debt securities are classified as held-to-maturity when the Company has the positive intent and ability to hold the securities to maturity. Debt securities for which the Company does not have the intent or ability to hold to maturity are classified as available-for-sale. Held-to-maturity securities are recorded as either short term or long term on the consolidated balance sheet, based on contractual maturity date and are stated at amortized cost. Debt securities that are bought and held principally for the purpose of selling them in the near term are classified as trading securities and are reported at fair value, with unrealized gains and losses recognized in earnings. Debt securities not classified as held-to-maturity or as trading are classified as available-for-sale, and are carried at fair value, with the unrealized gains and losses, net of tax, included in the determination of comprehensive income and reported in members’ equity. At March 31, 2023, the Company held an investment in debt securities that was classified as held-to-maturity and consisted of the following:

 

   Amortized
Costs		  Unrealized
Loss
United States Treasury Obligation  $978,860   $(236)

  

NOTE 7 - INCOME TAXES

 

The Company recorded no income tax expense for the six months ended March 31, 2023 and 2022 because the estimated annual effective tax rate was zero. As of March 31, 2023, the Company continues to provide a valuation allowance against its net deferred tax assets since the Company believes it is more likely than not that its deferred tax assets will not be realized.

 

NOTE 8 – STOCKHOLDERS' DEFICIENCY

 

Preferred Stock:

 

Series A

 

At both March 31, 2023 and September 30, 2022, 885,000 shares of Series A Preferred Stock (“Series A Preferred”) were outstanding.

 

Series A Preferred pays a dividend of 8% per annum on the stated value and has a liquidation preference equal to the stated value of the shares ($885,000 liquidation preference as of March 31, 2023 and September 30, 2022 plus dividends in arrears as per below). Each share of Series A Preferred Stock has an initial stated value of $1.00 and is convertible into shares of the Company’s common stock at the rate of 10 for 1.

 

The Series A Preferred Stock was marketed through a private placement memorandum that included a reference to a ratchet provision which would have allowed the holders of the stock to claim a better conversion rate based on other stock transactions conducted by the Company during the three-year period following the original issuance of the shares. The Certificate of Designation does not contain a ratchet provision. Certain of the stock related transactions consummated by the Company during this time period may have triggered this ratchet provision, and thus created a claim by holders of the Series A Preferred Stock who purchased based on this representation for a greater conversion rate than initially provided. There have been no new developments related to the remaining Series A holders regarding this claim and the conversion rate of their Series A Preferred Stock. Changes to the preferred stock conversion ratio may result in modification or extinguishment accounting. That may result in a deemed preferred stock dividend which would reduce net income available to common stockholders in the calculation of earnings per share. Certain of the smaller Series A holders have already converted or provided notice of conversion of their shares. In respect of this claim, the Company and its outside counsel determined that it is not possible to offer an opinion regarding the outcome. An adverse outcome could materially increase the accumulated deficit.

 

The dividends are cumulative commencing on the issue date when and if declared by the Board of Directors. As of March 31, 2023, and September 30, 2022, dividends in arrears were $835,333 ($.96 per share) and $818,030 ($.92 per share), respectively.

 

Series B

 

Four million (4,000,000) shares of Series B Convertible Preferred Stock (“Series B Preferred”) have been authorized with a liquidation preference of $2.00 per share. Each share of Series B Preferred is convertible into ten shares of common stock. Holders of Series B Preferred have a right to a dividend (pro-rata to each holder) based on a percentage of the gross revenue earned by the Company in the United States, if any, and the number of outstanding shares of Series B Preferred, as follows: Year 1 - Total Dividend to all Series B holders = .03 x Gross Revenue in the U.S. Year 2 - Total Dividend to all Series B holders = .02 x Gross Revenue in the U.S. Year 3 - Total Dividend to all Series B holders = .01 x Gross Revenue in the U.S. At March 31, 2023, no shares of Series B Preferred are outstanding. 

 F-11 

 

NOTE 9 - STOCK-BASED COMPENSATION

 

The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance with FASB ASC 505, “Equity.” Costs are measured at the estimated fair value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earlier of a performance commitment or completion of performance by the provider of goods or services as defined by ASC 505.

 

NOTE 10- RELATED PARTY TRANSACTIONS

 

The Company’s principal executive offices are located in Little Falls, New Jersey. The headquarters is located in the offices of McCoy Enterprises LLC, an entity controlled by Mr. McCoy. The office is attached to his residence but has its own entrances, restroom and kitchen facilities.

 

The Company also maintains an office at Carbon & Polymer Research Inc. ("CPR") in Pennington, New Jersey, which is the Company's materials and testing laboratory. An officer of the Company is an owner of CPR.

 

The Company paid rent in the amount of $24,610 for the six months ended March 31, 2023. No rent was charged previously.

 

On May 16, 2016, the Company entered into an agreement with CPR in which CPR will supply the collagen scaffolds used in the Company's production of the skin tissue. The contract contains a most favored customer clause guaranteeing the Company prices equal or lower than those charged to other customers. The Company has not yet made purchases from CPR.

 

See Note 4 for loans payable to related parties.

 

NOTE 11 - SUBSEQUENT EVENTS

 

Management has evaluated subsequent events through the date of this filing.

 

 F-12 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Further information concerning our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the SEC.

 

Overview of key events during the first two quarters ended March 31, 2023

 

During the first two quarters ended March 31, 2023, we implemented a program of pre-packaging and transferring materials and rights to set amounts of our NovaDerm® product to certain individuals through new series LLCs. These individuals were interested in acquiring our product materials and rights for the purpose of transferring them to charitable foundations interested in medical solutions for burn victims.

 

As part of this process, in October 2022, we set up a new Nevada Series LLC called NovaDerm Product Package, LLC (“NPP LLC”). During November and December 2022, consistent with Nevada law governing this Master Series LLC, we establish twenty-five (25) individual series LLCs, identifying each with a series letter of A through T or AA through EE. Thus, each of these sub-entities were named NovaDerm Product Package Series A, LLC through Series T, LLC, and then Series AA to Series EE, LLC (or NPP-A through NPP-T and NPP-AA through NPP-EE for short).

 

Into each of these twenty-five individual Series LLCs, we contributed the right and exclusive ownership to a fixed amount of the bovine hides and corium we use as key materials in the preparation of our NovaDerm® product, as well as the right to designate: (a) the specific patient cultured skin to be prepared from these materials; (b) the amount of this cultured skin to be prepared up to a designated amount and (c) the medical facility to receive the fully prepared and processed NovaDerm® cultured skin from these materials (these materials and combined designation rights are collectively referred to herein as the “NovaDerm® Product Rights”). For NPP-A through NPP-T and NPP-AA through NPP-CC we designated 33,333 cm2 of these NovaDerm® Product Rights. For NPP-DD we designated 30,625 cm2 of NovaDerm® Product Rights and for NPP-EE we designated 54,950 cm2 of NovaDerm® Product Rights. Each contribution of each of the NovaDerm® Product Rights was provided in exchange for 100 membership interests in the Series LLC which represented 100% of all membership interests issued.

 

Immediately after this contribution, we transferred 1 membership interest, or 1% of each Series LLC, to an individual in exchange for their management of the individual Series LLC operations. Following this transfer, we transferred the remaining 99 membership interests, or 99% of each of the Series LLCs to various Limited Liability Companies held by individuals unknown to us, in exchange for a pre-agreed payment. These transfers were made beginning in November 2022 and ending before year end.

 

While we retain possession of the materials transferred in each Series LLC contribution, we have a continuing obligation to segregated and manage those materials as well as to prepare the NovaDerm® cultured skin product as designated by each Series LLC holder or their designate. The identified materials are currently set apart from other such materials and are being held by us pending the identification of the patient and medical facility as instructed by each NovaDerm® Product Rights holder. Notwithstanding this retention of possession by us, the ownership and legal title to the materials are retained and fully vested in the individual Series LLC or its designate, where it was transferred.

 

 4 

 

The above-described transfers of membership interests in the Series LLCs generated a substantial amount of cash which we are obligated to use for the completion of our NovaDerm IND and the administration of our product clinical trials. As a result, during the second quarter of this fiscal year, we engaged a global Clinical Research Organization (CRO) with extensive experience performing clinical trials and preparing INDs to assist us in preparing our detailed submittal to the FDA. No assurance, however, can be given as to the success or failure of such IND or clinical trials, or as to any future FDA decisions made following our IND submission.

 

Our major objective for 2023 remains to complete the requirements of our NovaDerm IND application and begin our clinical trials. It remains our estimate that the cost to finalize the IND will be approximately $1.9 million dollars, and the cost to complete Phase 1/2 of the clinical trial will be approximately 5.0 million dollars. The time frame for each of these will vary based on several, as yet, variable factors and thus cannot be provided with any assurance. Furthermore, there can be no assurance that we will be able to complete these tasks for these estimated amounts or that we will be successful in the proving out our NovaDerm® Product in this process. Indeed, clinic trials are notoriously difficult and expensive and are likely to result in additional unplanned costs and a denial of FDA approval.

 

As previously reported, our goal in obtaining funding for this process has been to minimize shareholders' dilution as much as possible. We believe the manner in which we structured our transfer of NovaDerm® Product Rights has successfully achieved this objective. We will continue to work with potential investors, as necessary, in order to pursue other necessary funding based on our stated objective of successfully completing our planned clinical trials and obtaining FDA approval for the commercial sale of our NovaDerm® Product. It has taken longer to raise the funds than originally estimated; however, we remain hopeful that our goal is now achievable.

 

In the preparation of the IND application, we will continue to develop the testing suggested by the FDA during our Pre-IND meeting. Our scaffold supplier continues to perform the FDA suggested testing on collagen processing which addresses Bovine Closed Herd requirements for the enhanced safety and traceability of the collagen scaffolds used to produce NovaDerm®. We will be entering into discussions and evaluation of possible clinical trial sites for NovaDerm® as we proceed through the FDA approval process. Our discussions so far have confirmed that patient recruitment and enrollment should be faster and less complicated than other clinical trials because of our Orphan Designation and the fact that the surgical protocol will be similar to the grafting procedures currently in use at most facilities. NovaDerm® should thus require minimal physician training and documentation to complete the clinical trial, when and if conducted.

 

While we are currently in the process of working with our CRO to prepare the IND for filing, because of the numerous factors involved in the process, including pre-clinical testing, we remain unable at this time to provide a detailed timeline for the filing of the NovaDerm® IND or the commencement of clinical trials. Our initial trials, subject to FDA approval, are planned to begin with a total of ten subjects and an Initial Data Safety Monitoring Board, (DSMB), review of safety on the first three subjects once they have reached 6 months follow-up. We do not intend to interrupt our trial waiting for the DSMB report. Our management’s approach is to set up the trials so as to allow for a seamless transition into commercial production upon approval. We have arranged for sufficient Bovine Closed Herd corium to produce sufficient collagen scaffolds to meet our needs for the clinical trials once the IND is approved.

 

Three board positions remain open on our Board of Directors.

 

Importantly, we are filing this quarterly report without our auditor’s review or any audit of our financial information or this report. Our reason for doing this is that we are still in the process of obtaining the completion of the audits of our past financial reports with our auditors for past years. Instead, we have provided herein information as typically presented in our 10Q quarterly report, including financial information, which has not been reviewed or audited by any independent outside source.

 

We intend, if and when complete, to file an amendment to this 10Q filing with such reviewed and audited financial information. We are unaware, at this time, when we will obtain the necessary review and audit of the current and past filings; however, we have been working on re-engaging our auditors and will continue to provide current information to investors and the public through our EDGAR filings and postings on our website.

 5 

 

Results of Operations for the Six Months Ended March 31, 2023 and 2022

We generated no revenues from September 6, 2007 (date of inception) to March 31, 2023. We do not expect to generate revenue until we are able to obtain FDA approval of our product.

 

We incurred operating expenses of $595,455 for the three months ended March 31, 2023, compared with operating expenses of $155,513 for the three months ended March 31, 2022. General and administrative expenses accounted for $163,199 of our operating expenses and $432,256 was from research and development for the three months ended March 31, 2023. The major difference and shift in operating expenses from the three months ended March 31, 2022 was accounted for by an increase in research and development expense of $432,256. Otherwise, all operating expenses during the three months ended March 31, 2023 were from General and Administrative expenses in the amount of $233,093 and $94,743 in research and development expense.

 

Net other expense was $18,494 for the three months ended March 31, 2023, as compared to net other income of $11,136 for the three months ended March 31, 2022. Other income and expenses for the three months ended March 31, 2022 consisted of interest expenses of $9,011. Other income and expenses for the same period ended 2022 consisted of an unrealized loss on securities loss of $2,125 and an interest expense of $9,011.

 

After provision for preferred stock dividends of $17,845, we recorded net loss of $649,252 for the three months ended March 31, 2023. By comparison, we recorded net loss of $184,107 for the three months ended March 31, 2022. Our net loss for the quarter ended March 31, 2022 was primarily the result of $155,513 of general and administrative expenses.

 

Liquidity and Capital Resources

 

As of March 31, 2023, we had cash of $10,880,109 and total current assets of $11,859,194. As of March 31, 2023, we had current liabilities of $18,070,283. We therefore had a working capital deficit of $6,211,089.

 

Operating activities used $690,074 in cash for the six months ended March 31, 2023. The decrease in cash was primarily attributable to funding the loss for the period and an increase in research and development expense.

 

Investing activities and financing activities provided no cash or cost during the reported period. Based on the Company's cash balance we have sought the safest available investments for our research and operations designated funds. There remains a risk of loss when investing  and or depositing funds in any investment vehicle.

We note that the value of the shares of Amarantus we obtained and which created income from that sale of assets transaction have declined significantly in value since the consummation of the agreement.

 

We have issued various promissory notes to meet our short-term demands, the terms of which are provided in the notes to the consolidated financial statements accompanying this report. While this source of bridge financing has been helpful in the short term to meet our financial obligations, we will need additional financing to fund our operations, continue with the FDA approval process, and implement our business plan. Our long-term financial needs are estimated at about $8-10 million.

 

 6 

  

Off Balance Sheet Arrangements

 

As of March 31, 2023, there were no off-balance sheet arrangements.

 

Going Concern

 

Our consolidated financial statements have been prepared assuming that we will continue as a going concern which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. We have incurred operating losses from inception, expect to incur further losses in the development of our business, and have been dependent on funding operations through the issuance of convertible debt and private sale of equity securities. These conditions raise substantial doubt about our ability to continue as a going concern. Management’s plans include continuing to finance operations through the private or public placement of debt and/or equity securities and the reduction of expenditures. However, no assurance can be given at this time as to whether we will be able to achieve these objectives. The consolidated financial statements do not include any adjustment relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

A smaller reporting company is not required to provide the information required by this Item.

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of March 31, 2023. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2023, our disclosure controls and procedures were not effective due to presence of material weaknesses in internal control over financial reporting.

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has identified the following material weaknesses which have caused management to conclude that, as of March 31, 2023, our disclosure controls and procedures were not effective: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines.

 

Remediation Plan to Address the Material Weaknesses in Internal Control over Financial Reporting

 

Our company plans to take steps to enhance and improve the design of our internal controls over financial reporting. During the period covered by this quarterly report on Form 10-Q, we have not been able to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes during our fiscal year ending September 30, 2023 assuming we are able to obtain necessary funding or alternative financing: (i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management; and (ii) adopt sufficient written policies and procedures for accounting and financial reporting.

 

We are unable to remedy our controls related to the inadequate segregation of duties and ineffective risk management until we have hired sufficient qualified staff to perform the necessary functions.  

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the three months ended March 31, 2023 that have materially affected, or are reasonable likely to materially affect, our internal control over financial reporting.

  

 7 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings 

 

We are not a party to any pending legal proceeding. We are not aware of any pending legal proceeding to which any of our officers, directors, or any beneficial holders of 5% or more of our voting securities are adverse to us or have a material interest adverse to us.

 

Item 1A. Risk Factors

 

A smaller reporting company is not required to provide the information required by this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 

 

The information set forth below relates to our issuances of securities without registration under the Securities Act of 1933 during the reporting period which were not previously included in a Quarterly Report on Form 10-Q or Current Report on Form 8-K.

 

For the six months ended March 31, 2023, no shares of common stock have been issued for the conversion of principal issued under our bridge financing and accrued interest.

 

These securities were issued pursuant to Section 4(2) of the Securities Act and/or Rule 506 promulgated thereunder. The holders expressed their intention to acquire the securities for investment only and not with a view towards distribution. The investors were given adequate information about us to make an informed investment decision. We did not engage in any general solicitation or advertising. We directed our transfer agent to issue the stock certificates with the appropriate restrictive legend affixed to the restricted stock.

 

Item 3. Defaults upon Senior Securities

 

None

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None

 

Item 6. Exhibits

 

Exhibit Number Description of Exhibit
31.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101** The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 formatted in Inline eXtensible Business Reporting Language (iXBRL).
**Provided herewith

 

 8 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Regenicin, Inc.
   
Date: May 15, 2023
   
By: /s/ Randall McCoy
  Randall McCoy
Title: Chief Executive Officer and Director
(Principal Executive Officer)

 

By: /s/ John J. Weber
  John J. Weber
Title: Chief Financial Officer and Director
(Principal Financial Officer)

 

 9 

 

 EX-31.1 2 ex31_1.htm EX-31.1

CERTIFICATIONS

 

I, Randall McCoy, certify that;

 

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2023 of Regenicin, Inc (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 15, 2023

 

 

/s/ Randall McCoy

By: Randall McCoy

Title: Chief Executive Officer

 EX-31.2 3 ex31_2.htm EX-31.2

CERTIFICATIONS

 

I, John J. Weber, certify that;

 

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2023 of Regenicin, Inc (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 15, 2023

 

 

/s/ John J. Weber

By: John J. Weber

Title: Chief Financial Officer

 EX-32.1 4 ex32_1.htm EX-32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly Report of Regenicin, Inc (the “Company”) on Form 10-Q for the quarter ended March 31, 2023 filed with the Securities and Exchange Commission (the “Report”), I, Randall McCoy, Chief Executive Officer of the Company, and, I John J. Weber, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) and Section 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

 

By: /s/ Randall McCoy
Name: Randall McCoy
Title: Principal Executive Officer and Director
Date: May 15, 2023

By: /s/ John J. Weber
Name: John J. Weber
Title: Principal Financial Officer and Director
Date: May 15, 2023

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 EX-101.SCH 5 rgin-20230331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - THE COMPANY link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - LOANS PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - BRIDGE FINANCING link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - STOCKHOLDERS' DEFICIENCY link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - LOSS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - THE COMPANY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Schedule of Income per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Income Loss per Common Share Exclusion (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - BASIS OF PRESENTATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - LOANS PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - BRIDGE FINANCING (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Investment in Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - STOCKHOLDERS' DEFICIENCY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 rgin-20230331_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 rgin-20230331_def.xml XBRL DEFINITION FILE EX-101.LAB 8 rgin-20230331_lab.xml XBRL LABEL FILE Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Treasury Stock, Common [Member] Financial Instrument [Axis] A M B S [Member] Debt Instrument [Axis] Chief Financial Officer [Member] Chief Science Officer [Member] Chief Executive Officer [Member] Short-Term Debt, Type [Axis] Notes Payable [Axis] Promissory Note 2 [Member] Investment Type [Axis] Amtorized Costs [Member] Unrealized Loss [Member] Class of Stock [Axis] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash Investment, at amortized cost Common stock of Amarantus Total current and total assets LIABILITIES AND STOCKHOLDERS' DEFICIENCY CURRENT LIABILITIES Accounts payable Accrued expenses - other (related party of $75,389 and $65,471) Accrued salaries - officers Deferred income Promissory note payable Convertible promissory note - officer Loan payable Loans payable - officer Total current liabilities STOCKHOLDERS' DEFICIENCY Series A 8% Convertible Preferred stock, $0.001 par value, 5,500,000 shares authorized; 885,000 issued and outstanding Common stock, $0.001 par value; 200,000,000 shares authorized; 157,911,410 issued and 153,483,050 outstanding Additional paid-in capital Accumulated deficit Less: treasury stock; 4,428,360 shares at par Total stockholders' deficiency Total liabilities and stockholders' deficiency [custom:AccruedLiabilitiesCurrentRelatedParties-0] SeriesAPreferredStockAtParValue SeriesASharesAuthorized SeriesASharesIssued Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Treasury Stock, Common, Shares Income Statement [Abstract] Revenues Operating expenses Research and development General and administrative Total operating expenses Operating loss before other operating income Other operating income - reversal of accounts payable Other income (expenses) Interest expense (related party of $9,918, $9,132, $4,984 and $4,600) Interest income on held-to-maturity investment Change in unrealized gain (loss) on securities Total other expenses Net loss Preferred stock dividends Net loss attributable to common stockholders Loss per share basic Loss per share diluted Weighted average number of shares outstanding basic Weighted average number of shares outstanding diluted Interest Expense, Other Statement [Table] Statement [Line Items] Beginning balance, value Shares, Outstanding, Beginning Balance Net Loss Ending balance, value Shares, Outstanding, Ending Balance Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to reconcile net loss to net cash used in operating activities: Unrealized loss on investment Accrued interest on loans and notes payable Accretion of discount on held-to-maturity investment Changes in operating assets and liabilities Accounts payable Accrued expenses - other Accrued salaries - officers Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES Proceeds of loans from officers Proceeds from the sale of partnership interests Net cash provided by financing activities NET INCREASE IN CASH CASH - BEGINNING OF PERIOD CASH - END OF PERIOD Supplemental disclosures of cash flow information: Cash paid for interest Cash paid for taxes Organization, Consolidation and Presentation of Financial Statements [Abstract] THE COMPANY Accounting Policies [Abstract] BASIS OF PRESENTATION LOSS PER SHARE Loans Payable LOANS PAYABLE Receivables [Abstract] BRIDGE FINANCING Investments, Debt and Equity Securities [Abstract] INVESTMENTS Income Tax Disclosure [Abstract] INCOME TAXES Equity [Abstract] STOCKHOLDERS' DEFICIENCY STOCK-BASED COMPENSATION Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Subsequent Events [Abstract] SUBSEQUENT EVENTS Interim Financial Statements: Going Concern: Financial Instruments and Fair Value Measurement: Recently Issued Accounting Pronouncements: Schedule of Income per Common Share Income Loss per Common Share Exclusion Investment in Debt Securities Entity Incorporation, Date of Incorporation Options Convertible Preferred Stock Convertible Promissory Note Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table] Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] Common Stock, Value, Issued Unrealized Gain (Loss) on Investments Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Loans Payable Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Maturity Date Debt Instrument, Increase, Accrued Interest Loans Payable, Current [custom:LoansPayableRelatedParties] NotesPayableAxis [Axis] Debt Instrument, Issuance Date Debt Instrument, Face Amount [custom:DebtInstrumentAdditionalInterestRateStatedPercentage-0] [custom:BalanceOfConvertibleNotesPayable-0] Accrued Liabilities and Other Liabilities Schedule of Investments [Table] Schedule of Investments [Line Items] United States Treasury Obligation Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] [custom:SeriesASharesIssued-0] Debt Conversion, Converted Instrument, Rate Preferred Stock, Convertible, Conversion Price Dividends Payable, Current [custom:SeriesBSharesAuthorized-0] [custom:DividendStatedValue] Payments for Rent Assets Liabilities, Current Retained Earnings (Accumulated Deficit) Treasury Stock, Value Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Operating Expenses Interest Expense Other Expenses Dividends, Preferred Stock, Cash Equity, Attributable to Parent Shares, Outstanding Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Accrued Salaries Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Equity [Text Block] Loans Payable [Default Label] EX-101.PRE 9 rgin-20230331_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - shares
 6 Months Ended
Mar. 31, 2023
Apr. 04, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2023  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --09-30  
Entity File Number 333-146834  
Entity Registrant Name Regenicin, Inc.  
Entity Central Index Key 0001412659  
Entity Tax Identification Number 27-3083341  
Entity Incorporation, State or Country Code WY  
Entity Address, Address Line One 10 High Court  
Entity Address, City or Town Little Falls  
Entity Address, State or Province NJ  
Entity Address, Postal Zip Code 07424  
City Area Code 973  
Local Phone Number 557-8914  
Title of 12(b) Security COMMON  
Entity Current Reporting Status No  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   153,483,050
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2023
Sep. 30, 2022
CURRENT ASSETS    
Cash $ 10,880,109 $ 14,568
Investment, at amortized cost 978,860
Common stock of Amarantus 225 925
Total current and total assets 11,859,194 15,493
CURRENT LIABILITIES    
Accounts payable 103,119
Accrued expenses - other (related party of $75,389 and $65,471) 281,739 254,595
Accrued salaries - officers 4,612,001 4,612,001
Deferred income 12,533,625
Promissory note payable 175,000 175,000
Convertible promissory note - officer 335,683 335,683
Loan payable 10,000 10,000
Loans payable - officer 122,235 122,235
Total current liabilities 18,070,283 5,612,633
STOCKHOLDERS' DEFICIENCY    
Series A 8% Convertible Preferred stock, $0.001 par value, 5,500,000 shares authorized; 885,000 issued and outstanding 885 885
Common stock, $0.001 par value; 200,000,000 shares authorized; 157,911,410 issued and 153,483,050 outstanding 157,914 157,914
Additional paid-in capital 10,208,339 10,208,339
Accumulated deficit (16,573,799) (15,959,850)
Less: treasury stock; 4,428,360 shares at par (4,428) (4,428)
Total stockholders' deficiency (6,211,089) (5,597,140)
Total liabilities and stockholders' deficiency $ 11,859,194 $ 15,493
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Mar. 31, 2023
Sep. 30, 2022
Statement of Financial Position [Abstract]    
[custom:AccruedLiabilitiesCurrentRelatedParties-0] $ 75,389 $ 65,471
SeriesAPreferredStockAtParValue $ 0.001 $ 0.001
SeriesASharesAuthorized 5,500,000 5,500,000
SeriesASharesIssued 885,000 885,000
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized 200,000,000 200,000,000
Common Stock, Shares, Issued 157,911,410 157,911,410
Common Stock, Shares, Outstanding 153,483,050 153,483,050
Treasury Stock, Common, Shares 4,428,360 4,428,360
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]        
Revenues
Operating expenses        
Research and development 94,743 432,256
General and administrative 233,093 155,513 163,199 302,045
Total operating expenses 327,836 155,513 595,455 302,045
Operating loss before other operating income (327,836) (155,513) (595,455) (302,045)
Other operating income - reversal of accounts payable 0 0 0 0
Other income (expenses)        
Interest expense (related party of $9,918, $9,132, $4,984 and $4,600) (9,249) (9,011) (18,644) (17,954)
Interest income on held-to-maturity investment 850 850
Change in unrealized gain (loss) on securities (200) (2,125) (700) (775)
Total other expenses (8,599) (11,136) (18,494) (18,729)
Net loss (336,435) (166,649) (613,949) (320,774)
Preferred stock dividends (17,458) (17,458) (35,303) (35,303)
Net loss attributable to common stockholders $ (353,893) $ (184,107) $ (649,252) $ (356,077)
Loss per share basic $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Loss per share diluted $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Weighted average number of shares outstanding basic 153,483,050 153,483,050 153,483,050 153,483,050
Weighted average number of shares outstanding diluted 153,483,050 153,483,050 153,483,050 153,483,050
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]        
Interest Expense, Other $ 4,984 $ 4,600 $ 9,918 $ 9,132
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Common [Member]
Total
Beginning balance, value at Sep. 30, 2021 $ 885 $ 157,914 $ 10,208,339 $ (15,320,588) $ (4,428) $ (4,957,878)
Shares, Outstanding, Beginning Balance at Sep. 30, 2021 885,000 157,911,410        
Net Loss (154,125) (154,125)
Ending balance, value at Dec. 31, 2021 885 $ 157,914 10,208,339 (15,474,713) (4,428) (5,112,003)
Shares, Outstanding, Ending Balance at Dec. 31, 2021   157,911,410        
Beginning balance, value at Sep. 30, 2021 $ 885 $ 157,914 10,208,339 (15,320,588) (4,428) (4,957,878)
Shares, Outstanding, Beginning Balance at Sep. 30, 2021 885,000 157,911,410        
Net Loss           (320,774)
Ending balance, value at Mar. 31, 2022 $ 885 $ 157,914 10,208,339 (15,641,362) (4,428) (5,278,652)
Shares, Outstanding, Ending Balance at Mar. 31, 2022 885,000 157,911,410        
Beginning balance, value at Dec. 31, 2021 $ 885 $ 157,914 10,208,339 (15,474,713) (4,428) (5,112,003)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021   157,911,410        
Net Loss (166,649) (166,649)
Ending balance, value at Mar. 31, 2022 $ 885 $ 157,914 10,208,339 (15,641,362) (4,428) (5,278,652)
Shares, Outstanding, Ending Balance at Mar. 31, 2022 885,000 157,911,410        
Beginning balance, value at Sep. 30, 2022 $ 885 $ 157,914 10,208,339 (15,959,850) (4,428) (5,597,140)
Shares, Outstanding, Beginning Balance at Sep. 30, 2022 885,000 157,911,410        
Net Loss (277,514) (277,514)
Ending balance, value at Dec. 31, 2022 $ 885 $ 157,914 10,208,339 (16,297,135) (4,428) (5,934,425)
Shares, Outstanding, Ending Balance at Dec. 31, 2022 885,000 157,911,410        
Beginning balance, value at Sep. 30, 2022 $ 885 $ 157,914 10,208,339 (15,959,850) (4,428) (5,597,140)
Shares, Outstanding, Beginning Balance at Sep. 30, 2022 885,000 157,911,410        
Net Loss           (613,949)
Ending balance, value at Mar. 31, 2023 $ 885 $ 157,914 10,208,339 (16,574,649) (4,428) (6,211,939)
Shares, Outstanding, Ending Balance at Mar. 31, 2023 885,000 157,911,410        
Beginning balance, value at Dec. 31, 2022 $ 885 $ 157,914 10,208,339 (16,297,135) (4,428) (5,934,425)
Shares, Outstanding, Beginning Balance at Dec. 31, 2022 885,000 157,911,410        
Net Loss (336,435) (336,435)
Ending balance, value at Mar. 31, 2023 $ 885 $ 157,914 $ 10,208,339 $ (16,574,649) $ (4,428) $ (6,211,939)
Shares, Outstanding, Ending Balance at Mar. 31, 2023 885,000 157,911,410        
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (613,949) $ (320,774)
Adjustments to reconcile net loss to net cash used in operating activities:    
Unrealized loss on investment 700 775
Accrued interest on loans and notes payable 18,644 17,954
Accretion of discount on held-to-maturity investment (850)
Accounts payable (103,119) (8,676)
Accrued expenses - other 8,500 3,075
Accrued salaries - officers 290,500
Net cash used in operating activities (690,074) (17,146)
CASH FLOWS FROM INVESTING ACTIVITIES    
Proceeds of loans from officers 17,000
Proceeds from the sale of partnership interests (978,010)
Net cash provided by financing activities (978,010) 17,000
NET INCREASE IN CASH 10,865,541 (146)
CASH - BEGINNING OF PERIOD 14,568 1,859
CASH - END OF PERIOD 10,880,109 1,713
Supplemental disclosures of cash flow information:    
Cash paid for interest
Cash paid for taxes
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.1
THE COMPANY
 6 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
THE COMPANY

NOTE 1 - THE COMPANY

 

Regenicin, Inc. ("Regenicin"), formerly known as Windstar, Inc., was incorporated in the state of Nevada on September 6, 2007. On July 19, 2010, the Company amended its Articles of Incorporation to change the name of the Company to Regenicin, Inc. On August 31, 2022, we filed articles of continuance with the states of Nevada and Wyoming effectively moving our organizational jurisdiction from Nevada to Wyoming effective on that date. The Company's business plan is to develop and commercialize a potentially lifesaving technology by the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a variety of plastic surgery procedures.

 

In October 2022, the Company set up a new Nevada Series LLC called NovaDerm Product Package, LLC (“NPP LLC”). During November and December 2022, consistent with Nevada law governing this Master Series LLC, the Company established twenty-five (25) individual series LLCs, identifying each with a series letter of A through T or AA through EE. Thus, each of these sub-entities were named NovaDerm Product Package Series A, LLC through Series T, LLC, and then Series AA to Series EE, LLC (or NPP-A through NPP-T and NPP-AA through NPP-EE for short).

 

Into each of these twenty-five individual Series LLCs, the Company contributed the right and exclusive ownership to a certain amount of the bovine hides and corium that the Company currently owned and used as key materials in the preparation of its NovaDerm® product, as well as the right to designate: (a) the specific patient cultured skin to be prepared from these materials; (b) the amount of this cultured skin to be prepared up to a designated amount and (c) the medical facility to receive the fully prepared and processed NovaDerm® cultured skin from these materials (these materials and combined designation rights are collectively referred to herein as the “NovaDerm® Product Rights”). For NPP-A through NPP-T and NPP-AA through NPP-CC the Company designated 33,333 cm2 of these NovaDerm® Product Rights. For NPP-DD they designated 30,625 cm2 of NovaDerm® Product Rights and for NPP-EE they designated 28,783 cm2 of NovaDerm® Product Rights. Each contribution of each of the NovaDerm® Product Rights was provided in exchange for 100 membership interests in the Series LLC which represented 100% of all membership interests issued.

 

The Company subsequently transferred 99% of their membership interests (or 99 membership interests) in each of these Series LLC to various Limited Liability Companies, held by individuals unknown to us, in exchange for a pre-agreed payment. Prior to December 31, 2022, the members of these LLCs voted to donate 100% of the membership interests to charity.

 

While the Company retains possession of the materials transferred in each Series LLC contribution, the Company has a continuing obligation to segregate and manage those materials as well as to prepare the NovaDerm® cultured skin product as designated by each Series LLC holder or their designate. The identified materials are currently set apart from other such materials and are being held by the Company pending the identification of the patient and medical facility as instructed by each NovaDerm® Product Rights holder. Notwithstanding this retention of possession by the Company, the ownership and legal title to the materials are retained and fully vested in the individual Series LLC or its designate.

 

The above-described transfers of membership interests in the Series LLCs generated a substantial amount of cash which we are obligated to use for the completion of our NovaDerm IND and the administration of our product clinical trials. No assurance, however, can be given as to the success or failure of such IND or clinical trials, or as to any future FDA decisions made following these trials. Due to the continuing obligation the Company recorded the amount received as deferred income.

 

 
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION
 6 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
BASIS OF PRESENTATION

NOTE 2 - BASIS OF PRESENTATION

 

Interim Financial Statements:

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and note disclosures required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of those of a recurring nature) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023, are not necessarily indicative of the results that may be expected for the year ending September 30, 2023. These unaudited consolidated financial statements should be read in conjunction with the unaudited consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2022, as filed with the Securities and Exchange Commission. The consolidated balance sheet as of September 30, 2022, contained herein has been derived from the unaudited consolidated financial statements as of September 30, 2022, but does not include all disclosures required by U.S. GAAP.

 

Going Concern:

 

The Company's consolidated financial statements have been prepared assuming that the Company will continue as a going concern which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses and as of March 31, 2023, has an accumulated deficit of approximately $16.6 million from inception, expects to incur further losses in the development of its business and has been dependent on funding operations through the issuance of convertible debt, private sale of equity securities, and recently the certain partnership interest. These conditions raise substantial doubt about the Company's ability to continue as a going concern. Currently management plans to finance operations through the private or public placement of debt and/or equity securities. However, no assurance can be given at this time as to whether the Company will be able to obtain such financing. The consolidated financial statements do not include any adjustment relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Financial Instruments and Fair Value Measurement:

 

As of October 1, 2018, the Company adopted ASU No. 2016-01, “Financial Instruments-Overall: Recognition and Measurement of Financial Assets and Financial Liabilities”. The new standard principally affects accounting standards for equity investments, financial liabilities where the fair value option has been elected, and the presentation and disclosure requirements for financial instruments. Upon the effective date of the new standards, all equity investments in unconsolidated entities, other than those accounted for using the equity method of accounting, will generally be measured at fair value through earnings. There no longer is an available-for-sale classification and therefore, no changes in fair value will be reported in other comprehensive income (loss) for equity securities with readily determinable fair values. As a result of the adoption, the Company recorded a cumulative effect adjustment of a $950 decrease to accumulated other comprehensive income, and a corresponding decrease to accumulated deficit, as of October 1, 2018.

 

Common stock of Amarantus BioScience Holdings, Inc. (“Amarantus”) is carried at fair value in the accompanying consolidated balance sheets. Fair value is determined under the guidelines of GAAP which defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Realized gains and losses, determined using the first-in, first-out (FIFO) method, and unrealized gains and losses are included in other income (expense) on the statement of operations.

 

The common stock of Amarantus is valued at the closing price reported on the active market on which the security is traded. This valuation methodology is considered to be using Level 1 inputs. The total value of Amarantus common stock at March 31, 2023 is $225. The change in unrealized loss for the six months ended March 31, 2023 and 2022 was $(700) and $(775) net of income taxes, respectively, and was reported as other income (expense).

 

Recently Issued Accounting Pronouncements:

 

Any recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the consolidated financial statements of the Company.

 

 
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.1
LOSS PER SHARE
 6 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
LOSS PER SHARE

NOTE 3 - LOSS PER SHARE

 

Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share gives effect to dilutive convertible securities, options, warrants and other potential common stock outstanding during the period; only in periods in which such effect is dilutive.

 

The following weighted average securities have been excluded from the calculation of net loss per share for the six months ended March 31, 2023 and 2022 as the exercise price was greater than the average market price of the common shares:

 

  2023   2022  
Options   11,771,344        11,771,334     

 

The following weighted average securities have been excluded from the calculation because the effect of including these potential shares was anti-dilutive due to the net losses incurred during the six months ended March 31, 2023 and 2022:

 

  2023  2022
Convertible Preferred Stock  8,850,000    8,850,000 
Convertible Promissory Note  99,889,073    19,072,770 
 108,739,073    36,694,114 

 
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.1
LOANS PAYABLE
 6 Months Ended
Mar. 31, 2023
Loans Payable  
LOANS PAYABLE

NOTE 4 – LOANS PAYABLE

 

Convertible Promissory Note – Officer

 

Through March 31, 2020, John Weber, the Company's Chief Financial Officer, advanced the Company a total of $335,683. On March 31, 2020, these advances were converted into a convertible promissory note. Interest on the note is computed at 5% per annum and accrues from the time of the advances until the maturity date. The original maturity date was September 30, 2020, at which time all the accrued interest and principal became due. The note has been extended several times and most recently to December 31, 2022. For the six and three months ended March 31, 2023 and 2022 interest totaling $9,918, $9,132, $4,984 and $4,600, respectively, was incurred. Accrued interest on the note was $75,389 and $65,471 at March 31, 2023 and September 30, 2022, respectively, which is included in accrued expenses on the accompanying consolidated balance sheets. The note is convertible at the option of Mr. Weber into shares of the Company's common stock at the prevailing market rate on the date of conversion.

 

Loan Payable:

 

In February 2011, an investor advanced $10,000. The loan does not bear interest and is due on demand. At both March 31, 2023 and September 30, 2022, the loan payable totaled $10,000.

 

Loans Payable - Officer:

 

Through September 30, 2020, J. Roy Nelson, the Company’s Chief Science Officer, made net advances to the Company totaling $26,935. The loans do not bear interest and are due on demand.

 

In September 2018, Randall McCoy, the Company’s Chief Executive Officer, advanced to the Company $4,500. The loan does not bear interest and is due on demand.

 

From July 2020 through September 2022, John Weber, the Company’s Chief Financial Officer, advanced to the Company $90,800. The loan bears interest at 5% per annum and is due on demand.

 
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.1
BRIDGE FINANCING
 6 Months Ended
Mar. 31, 2023
Receivables [Abstract]  
BRIDGE FINANCING

NOTE 5 - BRIDGE FINANCING

 

On December 21, 2011, the Company issued a $150,000 promissory note to an individual. The note bore interest so that the Company would repay $175,000 on the maturity date of June 21, 2012. Additional interest of 10% was charged on any late payments. The note was not paid at the maturity date and the Company is incurring additional interest as described above. At both March 31, 2023 and September 30, 2022, the note balance was $175,000. Interest expense was $8,726 for each of the six months ended March 31, 2023 and 2022. Accrued interest on the note was $186,664 and $179,938 as of March 31, 2023 and September 30, 2022, respectively, and is included in Accrued expenses - other in the accompanying consolidated balance sheets.

 
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.1
INVESTMENTS
 6 Months Ended
Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
INVESTMENTS

NOTE 6 - INVESTMENTS

 

The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such determinations at each consolidated balance sheet date. Debt securities are classified as held-to-maturity when the Company has the positive intent and ability to hold the securities to maturity. Debt securities for which the Company does not have the intent or ability to hold to maturity are classified as available-for-sale. Held-to-maturity securities are recorded as either short term or long term on the consolidated balance sheet, based on contractual maturity date and are stated at amortized cost. Debt securities that are bought and held principally for the purpose of selling them in the near term are classified as trading securities and are reported at fair value, with unrealized gains and losses recognized in earnings. Debt securities not classified as held-to-maturity or as trading are classified as available-for-sale, and are carried at fair value, with the unrealized gains and losses, net of tax, included in the determination of comprehensive income and reported in members’ equity. At March 31, 2023, the Company held an investment in debt securities that was classified as held-to-maturity and consisted of the following:

 

   Amortized
Costs		  Unrealized
Loss
United States Treasury Obligation  $978,860   $(236)

  
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES
 6 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 7 - INCOME TAXES

 

The Company recorded no income tax expense for the six months ended March 31, 2023 and 2022 because the estimated annual effective tax rate was zero. As of March 31, 2023, the Company continues to provide a valuation allowance against its net deferred tax assets since the Company believes it is more likely than not that its deferred tax assets will not be realized.

 
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' DEFICIENCY
 6 Months Ended
Mar. 31, 2023
Equity [Abstract]  
STOCKHOLDERS' DEFICIENCY

NOTE 8 – STOCKHOLDERS' DEFICIENCY

 

Preferred Stock:

 

Series A

 

At both March 31, 2023 and September 30, 2022, 885,000 shares of Series A Preferred Stock (“Series A Preferred”) were outstanding.

 

Series A Preferred pays a dividend of 8% per annum on the stated value and has a liquidation preference equal to the stated value of the shares ($885,000 liquidation preference as of March 31, 2023 and September 30, 2022 plus dividends in arrears as per below). Each share of Series A Preferred Stock has an initial stated value of $1.00 and is convertible into shares of the Company’s common stock at the rate of 10 for 1.

 

The Series A Preferred Stock was marketed through a private placement memorandum that included a reference to a ratchet provision which would have allowed the holders of the stock to claim a better conversion rate based on other stock transactions conducted by the Company during the three-year period following the original issuance of the shares. The Certificate of Designation does not contain a ratchet provision. Certain of the stock related transactions consummated by the Company during this time period may have triggered this ratchet provision, and thus created a claim by holders of the Series A Preferred Stock who purchased based on this representation for a greater conversion rate than initially provided. There have been no new developments related to the remaining Series A holders regarding this claim and the conversion rate of their Series A Preferred Stock. Changes to the preferred stock conversion ratio may result in modification or extinguishment accounting. That may result in a deemed preferred stock dividend which would reduce net income available to common stockholders in the calculation of earnings per share. Certain of the smaller Series A holders have already converted or provided notice of conversion of their shares. In respect of this claim, the Company and its outside counsel determined that it is not possible to offer an opinion regarding the outcome. An adverse outcome could materially increase the accumulated deficit.

 

The dividends are cumulative commencing on the issue date when and if declared by the Board of Directors. As of March 31, 2023, and September 30, 2022, dividends in arrears were $835,333 ($.96 per share) and $818,030 ($.92 per share), respectively.

 

Series B

 

Four million (4,000,000) shares of Series B Convertible Preferred Stock (“Series B Preferred”) have been authorized with a liquidation preference of $2.00 per share. Each share of Series B Preferred is convertible into ten shares of common stock. Holders of Series B Preferred have a right to a dividend (pro-rata to each holder) based on a percentage of the gross revenue earned by the Company in the United States, if any, and the number of outstanding shares of Series B Preferred, as follows: Year 1 - Total Dividend to all Series B holders = .03 x Gross Revenue in the U.S. Year 2 - Total Dividend to all Series B holders = .02 x Gross Revenue in the U.S. Year 3 - Total Dividend to all Series B holders = .01 x Gross Revenue in the U.S. At March 31, 2023, no shares of Series B Preferred are outstanding. 

 
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION
 6 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
STOCK-BASED COMPENSATION

NOTE 9 - STOCK-BASED COMPENSATION

 

The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance with FASB ASC 505, “Equity.” Costs are measured at the estimated fair value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earlier of a performance commitment or completion of performance by the provider of goods or services as defined by ASC 505.

 
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS
 6 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 10- RELATED PARTY TRANSACTIONS

 

The Company’s principal executive offices are located in Little Falls, New Jersey. The headquarters is located in the offices of McCoy Enterprises LLC, an entity controlled by Mr. McCoy. The office is attached to his residence but has its own entrances, restroom and kitchen facilities.

 

The Company also maintains an office at Carbon & Polymer Research Inc. ("CPR") in Pennington, New Jersey, which is the Company's materials and testing laboratory. An officer of the Company is an owner of CPR.

 

The Company paid rent in the amount of $24,610 for the six months ended March 31, 2023. No rent was charged previously.

 

On May 16, 2016, the Company entered into an agreement with CPR in which CPR will supply the collagen scaffolds used in the Company's production of the skin tissue. The contract contains a most favored customer clause guaranteeing the Company prices equal or lower than those charged to other customers. The Company has not yet made purchases from CPR.

 

See Note 4 for loans payable to related parties.

 
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
 6 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 11 - SUBSEQUENT EVENTS

 

Management has evaluated subsequent events through the date of this filing.
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION (Policies)
 6 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Interim Financial Statements:

Interim Financial Statements:

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and note disclosures required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of those of a recurring nature) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023, are not necessarily indicative of the results that may be expected for the year ending September 30, 2023. These unaudited consolidated financial statements should be read in conjunction with the unaudited consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2022, as filed with the Securities and Exchange Commission. The consolidated balance sheet as of September 30, 2022, contained herein has been derived from the unaudited consolidated financial statements as of September 30, 2022, but does not include all disclosures required by U.S. GAAP.

 
Going Concern:

Going Concern:

 

The Company's consolidated financial statements have been prepared assuming that the Company will continue as a going concern which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses and as of March 31, 2023, has an accumulated deficit of approximately $16.6 million from inception, expects to incur further losses in the development of its business and has been dependent on funding operations through the issuance of convertible debt, private sale of equity securities, and recently the certain partnership interest. These conditions raise substantial doubt about the Company's ability to continue as a going concern. Currently management plans to finance operations through the private or public placement of debt and/or equity securities. However, no assurance can be given at this time as to whether the Company will be able to obtain such financing. The consolidated financial statements do not include any adjustment relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 
Financial Instruments and Fair Value Measurement:

Financial Instruments and Fair Value Measurement:

 

As of October 1, 2018, the Company adopted ASU No. 2016-01, “Financial Instruments-Overall: Recognition and Measurement of Financial Assets and Financial Liabilities”. The new standard principally affects accounting standards for equity investments, financial liabilities where the fair value option has been elected, and the presentation and disclosure requirements for financial instruments. Upon the effective date of the new standards, all equity investments in unconsolidated entities, other than those accounted for using the equity method of accounting, will generally be measured at fair value through earnings. There no longer is an available-for-sale classification and therefore, no changes in fair value will be reported in other comprehensive income (loss) for equity securities with readily determinable fair values. As a result of the adoption, the Company recorded a cumulative effect adjustment of a $950 decrease to accumulated other comprehensive income, and a corresponding decrease to accumulated deficit, as of October 1, 2018.

 

Common stock of Amarantus BioScience Holdings, Inc. (“Amarantus”) is carried at fair value in the accompanying consolidated balance sheets. Fair value is determined under the guidelines of GAAP which defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Realized gains and losses, determined using the first-in, first-out (FIFO) method, and unrealized gains and losses are included in other income (expense) on the statement of operations.

 

The common stock of Amarantus is valued at the closing price reported on the active market on which the security is traded. This valuation methodology is considered to be using Level 1 inputs. The total value of Amarantus common stock at March 31, 2023 is $225. The change in unrealized loss for the six months ended March 31, 2023 and 2022 was $(700) and $(775) net of income taxes, respectively, and was reported as other income (expense).

 
Recently Issued Accounting Pronouncements:

Recently Issued Accounting Pronouncements:

 

Any recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the consolidated financial statements of the Company.
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.1
LOSS PER SHARE (Tables)
 6 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Schedule of Income per Common Share
  2023   2022  
Options   11,771,344        11,771,334     
Income Loss per Common Share Exclusion
  2023  2022
Convertible Preferred Stock  8,850,000    8,850,000 
Convertible Promissory Note  99,889,073    19,072,770 
 108,739,073    36,694,114 
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.1
INVESTMENTS (Tables)
 6 Months Ended
Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Investment in Debt Securities
   Amortized
Costs		  Unrealized
Loss
United States Treasury Obligation  $978,860   $(236)
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.1
THE COMPANY (Details Narrative)
 6 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Entity Incorporation, Date of Incorporation Sep. 06, 2007
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Income per Common Share (Details) - USD ($)
 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Accounting Policies [Abstract]    
Options $ 11,771,344 $ 11,771,334
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Income Loss per Common Share Exclusion (Details) - shares
 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Accounting Policies [Abstract]    
Convertible Preferred Stock 8,850,000 8,850,000
Convertible Promissory Note 99,889,073 19,072,770
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 108,739,073 36,694,114
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION (Details Narrative) - USD ($)
 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Sep. 30, 2022
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]      
Common Stock, Value, Issued $ 157,914   $ 157,914
Unrealized Gain (Loss) on Investments (700) $ (775)  
A M B S [Member]      
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]      
Common Stock, Value, Issued $ 225    
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.1
LOANS PAYABLE (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 27 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Sep. 30, 2022
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2018
Short-Term Debt [Line Items]                  
Debt Instrument, Interest Rate, Stated Percentage 5.00%     5.00%          
[custom:AccruedLiabilitiesCurrentRelatedParties-0] $ 75,389     $ 75,389   $ 65,471      
Loans Payable, Current 10,000     10,000   $ 10,000      
Chief Financial Officer [Member]                  
Short-Term Debt [Line Items]                  
Debt Instrument, Interest Rate, Stated Percentage           500.00%      
[custom:LoansPayableRelatedParties]           $ 90,800      
Chief Financial Officer [Member]                  
Short-Term Debt [Line Items]                  
Loans Payable               $ 335,683  
Debt Instrument, Maturity Date   Dec. 31, 2022              
Debt Instrument, Increase, Accrued Interest 4,984   $ 4,600 9,918 $ 9,132        
[custom:AccruedLiabilitiesCurrentRelatedParties-0] $ 75,389     $ 75,389   $ 65,471      
Chief Science Officer [Member]                  
Short-Term Debt [Line Items]                  
Loans Payable, Current             $ 26,935    
Chief Executive Officer [Member]                  
Short-Term Debt [Line Items]                  
Loans Payable                 $ 4,500
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.1
BRIDGE FINANCING (Details Narrative) - Promissory Note 2 [Member] - USD ($)
 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Sep. 30, 2022
Debt Instrument, Issuance Date Dec. 21, 2011    
Debt Instrument, Face Amount $ 150,000    
Debt Instrument, Maturity Date Jun. 21, 2012    
[custom:DebtInstrumentAdditionalInterestRateStatedPercentage-0] 1000.00%    
[custom:BalanceOfConvertibleNotesPayable-0] $ 175,000   $ 175,000
Debt Instrument, Increase, Accrued Interest 8,726 $ 8,726  
Accrued Liabilities and Other Liabilities $ 186,664   $ 179,938
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Investment in Debt Securities (Details)
Mar. 31, 2023
USD ($)
Amtorized Costs [Member]  
Schedule of Investments [Line Items]  
United States Treasury Obligation $ 978,860
Unrealized Loss [Member]  
Schedule of Investments [Line Items]  
United States Treasury Obligation $ (236)
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' DEFICIENCY (Details Narrative) - USD ($)
 6 Months Ended
Mar. 31, 2023
Sep. 30, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]    
[custom:SeriesASharesIssued-0] 885,000 885,000
Debt Conversion, Converted Instrument, Rate 8.00%  
[custom:DividendStatedValue] $ 2.00  
Preferred Stock [Member] | Series A Preferred Stock [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Preferred Stock, Convertible, Conversion Price $ 1.00  
Dividends Payable, Current $ 835,333 $ 818,030
Preferred Stock [Member] | Series B Preferred Stock [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
[custom:SeriesBSharesAuthorized-0] 4,000,000  
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details Narrative)
 6 Months Ended
Mar. 31, 2023
USD ($)
Related Party Transactions [Abstract]  
Payments for Rent $ 24,610
XML 40 rgin10q_htm.xml IDEA: XBRL DOCUMENT 0001412659 2022-10-01 2023-03-31 0001412659 2023-04-04 0001412659 2023-03-31 0001412659 2022-09-30 0001412659 2021-10-01 2022-03-31 0001412659 2023-01-01 2023-03-31 0001412659 2022-01-01 2022-03-31 0001412659 us-gaap:PreferredStockMember 2022-09-30 0001412659 us-gaap:CommonStockMember 2022-09-30 0001412659 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001412659 us-gaap:RetainedEarningsMember 2022-09-30 0001412659 us-gaap:TreasuryStockCommonMember 2022-09-30 0001412659 us-gaap:PreferredStockMember 2022-12-31 0001412659 us-gaap:CommonStockMember 2022-12-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001412659 us-gaap:RetainedEarningsMember 2022-12-31 0001412659 us-gaap:TreasuryStockCommonMember 2022-12-31 0001412659 2022-12-31 0001412659 us-gaap:PreferredStockMember 2021-09-30 0001412659 us-gaap:CommonStockMember 2021-09-30 0001412659 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001412659 us-gaap:RetainedEarningsMember 2021-09-30 0001412659 us-gaap:TreasuryStockCommonMember 2021-09-30 0001412659 2021-09-30 0001412659 us-gaap:PreferredStockMember 2021-12-31 0001412659 us-gaap:CommonStockMember 2021-12-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001412659 us-gaap:RetainedEarningsMember 2021-12-31 0001412659 us-gaap:TreasuryStockCommonMember 2021-12-31 0001412659 2021-12-31 0001412659 us-gaap:PreferredStockMember 2022-10-01 2022-12-31 0001412659 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001412659 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001412659 us-gaap:TreasuryStockCommonMember 2022-10-01 2022-12-31 0001412659 2022-10-01 2022-12-31 0001412659 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001412659 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001412659 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001412659 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001412659 us-gaap:PreferredStockMember 2021-10-01 2021-12-31 0001412659 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001412659 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001412659 us-gaap:TreasuryStockCommonMember 2021-10-01 2021-12-31 0001412659 2021-10-01 2021-12-31 0001412659 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001412659 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001412659 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001412659 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0001412659 us-gaap:PreferredStockMember 2023-03-31 0001412659 us-gaap:CommonStockMember 2023-03-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001412659 us-gaap:RetainedEarningsMember 2023-03-31 0001412659 us-gaap:TreasuryStockCommonMember 2023-03-31 0001412659 us-gaap:PreferredStockMember 2022-03-31 0001412659 us-gaap:CommonStockMember 2022-03-31 0001412659 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001412659 us-gaap:RetainedEarningsMember 2022-03-31 0001412659 us-gaap:TreasuryStockCommonMember 2022-03-31 0001412659 2022-03-31 0001412659 RGIN:AMBSMember 2023-03-31 0001412659 srt:ChiefFinancialOfficerMember 2020-03-31 0001412659 srt:ChiefFinancialOfficerMember 2022-10-01 2022-12-31 0001412659 srt:ChiefFinancialOfficerMember 2022-10-01 2023-03-31 0001412659 srt:ChiefFinancialOfficerMember 2021-10-01 2022-03-31 0001412659 srt:ChiefFinancialOfficerMember 2023-01-01 2023-03-31 0001412659 srt:ChiefFinancialOfficerMember 2022-01-01 2022-03-31 0001412659 srt:ChiefFinancialOfficerMember 2023-03-31 0001412659 srt:ChiefFinancialOfficerMember 2022-09-30 0001412659 RGIN:ChiefScienceOfficerMember 2020-09-30 0001412659 srt:ChiefExecutiveOfficerMember 2018-09-30 0001412659 srt:ChiefFinancialOfficerMember 2020-07-01 2022-09-30 0001412659 srt:ChiefFinancialOfficerMember 2022-09-30 0001412659 RGIN:PromissoryNote2Member 2022-10-01 2023-03-31 0001412659 RGIN:PromissoryNote2Member 2023-03-31 0001412659 RGIN:PromissoryNote2Member 2022-09-30 0001412659 RGIN:PromissoryNote2Member 2021-10-01 2022-03-31 0001412659 RGIN:AmtorizedCostsMember 2023-03-31 0001412659 RGIN:UnrealizedLossMember 2023-03-31 0001412659 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001412659 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001412659 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 iso4217:USD shares iso4217:USD shares pure 0001412659 Q1 --09-30 2023 false 10-Q true 2023-03-31 false 333-146834 Regenicin, Inc. WY 27-3083341 COMMON 10 High Court Little Falls NJ 07424 973 557-8914 No No Non-accelerated Filer true false false false 153483050 10880109 14568 978860 225 925 11859194 15493 103119 75389 65471 281739 254595 4612001 4612001 12533625 175000 175000 335683 335683 10000 10000 122235 122235 18070283 5612633 0.001 0.001 5500000 5500000 885000 885000 885 885 0.001 0.001 200000000 200000000 157911410 157911410 153483050 153483050 157914 157914 10208339 10208339 16573799 15959850 4428360 4428360 4428 4428 -6211089 -5597140 11859194 15493 432256 94743 163199 302045 233093 155513 595455 302045 327836 155513 -595455 -302045 -327836 -155513 0 0 0 0 9918 9132 4984 4600 18644 17954 9249 9011 850 850 -700 -775 -200 -2125 18494 18729 8599 11136 -613949 -320774 -336435 -166649 35303 35303 17458 17458 -649252 -356077 -353893 -184107 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 153483050 153483050 153483050 153483050 153483050 153483050 153483050 153483050 885000 885 157911410 157914 10208339 -15959850 -4428 -5597140 -277514 -277514 885000 885 157911410 157914 10208339 -16297135 -4428 -5934425 -336435 -336435 885000 885 157911410 157914 10208339 -16574649 -4428 -6211939 885000 885 157911410 157914 10208339 -15320588 -4428 -4957878 -154125 -154125 885000 885 157911410 157914 10208339 -15474713 -4428 -5112003 -166649 -166649 885000 885 157911410 157914 10208339 -15641362 -4428 -5278652 -613949 -320774 -700 -775 18644 17954 -850 -103119 -8676 8500 3075 290500 -690074 -17146 17000 -978010 -978010 17000 10865541 -146 14568 1859 10880109 1713 <p id="xdx_80F_eus-gaap--NatureOfOperations_zjteXlvckY56" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE 1 - <span id="xdx_823_z9bPzlQikfE">THE COMPANY</span></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regenicin, Inc. ("Regenicin"), formerly known as Windstar, Inc., was incorporated in the state of Nevada on <span id="xdx_906_edei--EntityIncorporationDateOfIncorporation_c20221001__20230331_zNa3sTEmWW95">September 6, 2007</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. On July 19, 2010, the Company amended its Articles of Incorporation to change the name of the Company to Regenicin, Inc. On August 31, 2022, we filed articles of continuance with the states of Nevada and Wyoming effectively moving our organizational jurisdiction from Nevada to Wyoming effective on that date. The Company's business plan is to develop and commercialize a potentially lifesaving technology by the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a variety of plastic surgery procedures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2022, the Company set up a new Nevada Series LLC called NovaDerm Product Package, LLC (“NPP LLC”). During November and December 2022, consistent with Nevada law governing this Master Series LLC, the Company established twenty-five (25) individual series LLCs, identifying each with a series letter of A through T or AA through EE. Thus, each of these sub-entities were named NovaDerm Product Package Series A, LLC through Series T, LLC, and then Series AA to Series EE, LLC (or NPP-A through NPP-T and NPP-AA through NPP-EE for short).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Into each of these twenty-five individual Series LLCs, the Company contributed the right and exclusive ownership to a certain amount of the bovine hides and corium that the Company currently owned and used as key materials in the preparation of its NovaDerm® product, as well as the right to designate: (a) the specific patient cultured skin to be prepared from these materials; (b) the amount of this cultured skin to be prepared up to a designated amount and (c) the medical facility to receive the fully prepared and processed NovaDerm® cultured skin from these materials (these materials and combined designation rights are collectively referred to herein as the “NovaDerm® Product Rights”). For NPP-A through NPP-T and NPP-AA through NPP-CC the Company designated 33,333 cm<sup>2</sup> of these NovaDerm® Product Rights. For NPP-DD they designated 30,625 cm<sup>2</sup> of NovaDerm® Product Rights and for NPP-EE they designated 28,783 cm<sup>2</sup> of NovaDerm® Product Rights. Each contribution of each of the NovaDerm® Product Rights was provided in exchange for 100 membership interests in the Series LLC which represented 100% of all membership interests issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company subsequently transferred 99% of their membership interests (or 99 membership interests) in each of these Series LLC to various Limited Liability Companies, held by individuals unknown to us, in exchange for a pre-agreed payment. Prior to December 31, 2022, the members of these LLCs voted to donate 100% of the membership interests to charity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">While the Company retains possession of the materials transferred in each Series LLC contribution, the Company has a continuing obligation to segregate and manage those materials as well as to prepare the NovaDerm® cultured skin product as designated by each Series LLC holder or their designate. The identified materials are currently set apart from other such materials and are being held by the Company pending the identification of the patient and medical facility as instructed by each NovaDerm® Product Rights holder. Notwithstanding this retention of possession by the Company, the ownership and legal title to the materials are retained and fully vested in the individual Series LLC or its designate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The above-described transfers of membership interests in the Series LLCs generated a substantial amount of cash which we are obligated to use for the completion of our NovaDerm IND and the administration of our product clinical trials. No assurance, however, can be given as to the success or failure of such IND or clinical trials, or as to any future FDA decisions made following these trials.<b> </b>Due to the continuing obligation the Company recorded the amount received as deferred income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2007-09-06 <p id="xdx_800_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zZgwrCr0qYMi" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE 2 - <span id="xdx_827_zmhJlUiqWza9">BASIS OF PRESENTATION</span></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zlIdbVMkHHRh" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Financial Statements:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and note disclosures required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of those of a recurring nature) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023, are not necessarily indicative of the results that may be expected for the year ending September 30, 2023. These unaudited consolidated financial statements should be read in conjunction with the unaudited consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2022, as filed with the Securities and Exchange Commission. The consolidated balance sheet as of September 30, 2022, contained herein has been derived from the unaudited consolidated financial statements as of September 30, 2022, but does not include all disclosures required by U.S. GAAP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zCsMo5uOVnHj" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going Concern:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company's consolidated financial statements have been prepared assuming that the Company will continue as a going concern which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses and as of March 31, 2023, has an accumulated deficit of approximately $16.6 million from inception, expects to incur further losses in the development of its business and has been dependent on funding operations through the issuance of convertible debt, private sale of equity securities, and recently the certain partnership interest. These conditions raise substantial doubt about the Company's ability to continue as a going concern. Currently management plans to finance operations through the private or public placement of debt and/or equity securities. However, no assurance can be given at this time as to whether the Company will be able to obtain such financing. The consolidated financial statements do not include any adjustment relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zYXVTNaTv5Mi" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Instruments and Fair Value Measurement:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of October 1, 2018, the Company adopted ASU No. 2016-01, “Financial Instruments-Overall: Recognition and Measurement of Financial Assets and Financial Liabilities”. The new standard principally affects accounting standards for equity investments, financial liabilities where the fair value option has been elected, and the presentation and disclosure requirements for financial instruments. Upon the effective date of the new standards, all equity investments in unconsolidated entities, other than those accounted for using the equity method of accounting, will generally be measured at fair value through earnings. There no longer is an available-for-sale classification and therefore, no changes in fair value will be reported in other comprehensive income (loss) for equity securities with readily determinable fair values. As a result of the adoption, the Company recorded a cumulative effect adjustment of a $950 decrease to accumulated other comprehensive income, and a corresponding decrease to accumulated deficit, as of October 1, 2018.</span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock of Amarantus BioScience Holdings, Inc. (“Amarantus”) is carried at fair value in the accompanying consolidated balance sheets. Fair value is determined under the guidelines of GAAP which defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Realized gains and losses, determined using the first-in, first-out (FIFO) method, and unrealized gains and losses are included in other income (expense) on the statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The common stock of Amarantus is valued at the closing price reported on the active market on which the security is traded. This valuation methodology is considered to be using Level 1 inputs. The total value of Amarantus common stock at March 31, 2023 is $<span id="xdx_90C_eus-gaap--CommonStockValue_iI_c20230331__us-gaap--FinancialInstrumentAxis__custom--AMBSMember_zgXJXTmZreP1">225</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The change in unrealized loss for the six months ended March 31, 2023 and 2022 was $<span id="xdx_904_eus-gaap--UnrealizedGainLossOnInvestments_c20221001__20230331_zv9MI7Z59sLk">(700) and</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_907_eus-gaap--UnrealizedGainLossOnInvestments_c20211001__20220331_zqQ2yvkaHrOg">(775) </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">net of income taxes, respectively, and was reported as other income (expense).</span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zMcIDcGP6uqh" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently Issued Accounting Pronouncements:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the consolidated financial statements of the Company.</span></p> <p id="xdx_851_z4OJtfD0Xdu5" style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 16.65pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zlIdbVMkHHRh" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Financial Statements:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and note disclosures required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of those of a recurring nature) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023, are not necessarily indicative of the results that may be expected for the year ending September 30, 2023. These unaudited consolidated financial statements should be read in conjunction with the unaudited consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2022, as filed with the Securities and Exchange Commission. The consolidated balance sheet as of September 30, 2022, contained herein has been derived from the unaudited consolidated financial statements as of September 30, 2022, but does not include all disclosures required by U.S. GAAP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zCsMo5uOVnHj" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going Concern:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company's consolidated financial statements have been prepared assuming that the Company will continue as a going concern which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses and as of March 31, 2023, has an accumulated deficit of approximately $16.6 million from inception, expects to incur further losses in the development of its business and has been dependent on funding operations through the issuance of convertible debt, private sale of equity securities, and recently the certain partnership interest. These conditions raise substantial doubt about the Company's ability to continue as a going concern. Currently management plans to finance operations through the private or public placement of debt and/or equity securities. However, no assurance can be given at this time as to whether the Company will be able to obtain such financing. The consolidated financial statements do not include any adjustment relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zYXVTNaTv5Mi" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Instruments and Fair Value Measurement:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of October 1, 2018, the Company adopted ASU No. 2016-01, “Financial Instruments-Overall: Recognition and Measurement of Financial Assets and Financial Liabilities”. The new standard principally affects accounting standards for equity investments, financial liabilities where the fair value option has been elected, and the presentation and disclosure requirements for financial instruments. Upon the effective date of the new standards, all equity investments in unconsolidated entities, other than those accounted for using the equity method of accounting, will generally be measured at fair value through earnings. There no longer is an available-for-sale classification and therefore, no changes in fair value will be reported in other comprehensive income (loss) for equity securities with readily determinable fair values. As a result of the adoption, the Company recorded a cumulative effect adjustment of a $950 decrease to accumulated other comprehensive income, and a corresponding decrease to accumulated deficit, as of October 1, 2018.</span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock of Amarantus BioScience Holdings, Inc. (“Amarantus”) is carried at fair value in the accompanying consolidated balance sheets. Fair value is determined under the guidelines of GAAP which defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Realized gains and losses, determined using the first-in, first-out (FIFO) method, and unrealized gains and losses are included in other income (expense) on the statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The common stock of Amarantus is valued at the closing price reported on the active market on which the security is traded. This valuation methodology is considered to be using Level 1 inputs. The total value of Amarantus common stock at March 31, 2023 is $<span id="xdx_90C_eus-gaap--CommonStockValue_iI_c20230331__us-gaap--FinancialInstrumentAxis__custom--AMBSMember_zgXJXTmZreP1">225</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The change in unrealized loss for the six months ended March 31, 2023 and 2022 was $<span id="xdx_904_eus-gaap--UnrealizedGainLossOnInvestments_c20221001__20230331_zv9MI7Z59sLk">(700) and</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_907_eus-gaap--UnrealizedGainLossOnInvestments_c20211001__20220331_zqQ2yvkaHrOg">(775) </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">net of income taxes, respectively, and was reported as other income (expense).</span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 225 -700 -775 <p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zMcIDcGP6uqh" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently Issued Accounting Pronouncements:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the consolidated financial statements of the Company.</span></p> <p id="xdx_805_eus-gaap--EarningsPerSharePolicyTextBlock_zURKP3YKKs71" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE 3 - <span id="xdx_823_zQICsUbCy6w1">LOSS PER SHARE</span></span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share gives effect to dilutive convertible securities, options, warrants and other potential common stock outstanding during the period; only in periods in which such effect is dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following weighted average securities have been excluded from the calculation of net loss per share for the six months ended March 31, 2023 and 2022 as the exercise price was greater than the average market price of the common shares:</span></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zywJHlNwDPzc" style="margin-left: auto; width: 40%; border-collapse: collapse; margin-right: auto" summary="xdx: Disclosure - Schedule of Income per Common Share (Details)"> <tr> <td style="font: 12pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td colspan="3" id="xdx_49F_20221001__20230331_zFxYhPWjyta7" style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">2023</span></td> <td style="font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_499_20211001__20220331_zfukvdCwrwM4" style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">2022</span></td> <td style="font: 12pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_ze2v372VZOjh" style="vertical-align: bottom"> <td style="font: 12pt Times New Roman, Times, Serif; width: 54%; background-color: #CCEECC; padding-bottom: 1pt"><span style="font-size: 10pt">Options</span></td> <td style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 1%; background-color: #CCEECC"> </td> <td style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 20%; background-color: #CCEECC; text-align: right"><span style="font-size: 10pt">11,771,344 </span></td> <td style="font: 12pt Times New Roman, Times, Serif; width: 1%; background-color: #CCEECC; padding-bottom: 1pt"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 1%; background-color: #CCEECC; padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 1%; background-color: #CCEECC"> </td> <td style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 20%; background-color: #CCEECC; text-align: right"><span style="font-size: 10pt">11,771,334 </span></td> <td style="font: 12pt Times New Roman, Times, Serif; width: 1%; background-color: #CCEECC; padding-bottom: 1pt"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 1%"> </td></tr> </table> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt/106% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">The following weighted average securities have been excluded from the calculation because the effect of including these potential shares was anti-dilutive due to the net losses incurred during the six months ended March 31, 2023</span> and 2022:</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zN9Wlf9yLjd2" style="font: 9.5pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - Income Loss per Common Share Exclusion (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_491_20221001__20230331_zhmcwtHwYhR8" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_499_20211001__20220331_zStA9gSonJI3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr> <tr id="xdx_402_ecustom--ConvertiblePreferredStockIssuableUponConversionAndExercise_uShares_zIjoGxTv3Ghe" style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="font-size: 10pt; text-align: left; width: 54%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Preferred Stock</span></td> <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,850,000</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,850,000</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--ConvertiblePromissoryNoteIssuable_uShares_zRGYxfnlzRp" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Promissory Note</span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99,889,073</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,072,770</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zr4hU5NiYOV5" style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,739,073</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,694,114</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zywJHlNwDPzc" style="margin-left: auto; width: 40%; border-collapse: collapse; margin-right: auto" summary="xdx: Disclosure - Schedule of Income per Common Share (Details)"> <tr> <td style="font: 12pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td colspan="3" id="xdx_49F_20221001__20230331_zFxYhPWjyta7" style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">2023</span></td> <td style="font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_499_20211001__20220331_zfukvdCwrwM4" style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">2022</span></td> <td style="font: 12pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_ze2v372VZOjh" style="vertical-align: bottom"> <td style="font: 12pt Times New Roman, Times, Serif; width: 54%; background-color: #CCEECC; padding-bottom: 1pt"><span style="font-size: 10pt">Options</span></td> <td style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 1%; background-color: #CCEECC"> </td> <td style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 20%; background-color: #CCEECC; text-align: right"><span style="font-size: 10pt">11,771,344 </span></td> <td style="font: 12pt Times New Roman, Times, Serif; width: 1%; background-color: #CCEECC; padding-bottom: 1pt"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 1%; background-color: #CCEECC; padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 1%; background-color: #CCEECC"> </td> <td style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 20%; background-color: #CCEECC; text-align: right"><span style="font-size: 10pt">11,771,334 </span></td> <td style="font: 12pt Times New Roman, Times, Serif; width: 1%; background-color: #CCEECC; padding-bottom: 1pt"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 1%"> </td></tr> </table> 11771344 11771334 <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zN9Wlf9yLjd2" style="font: 9.5pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - Income Loss per Common Share Exclusion (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_491_20221001__20230331_zhmcwtHwYhR8" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_499_20211001__20220331_zStA9gSonJI3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr> <tr id="xdx_402_ecustom--ConvertiblePreferredStockIssuableUponConversionAndExercise_uShares_zIjoGxTv3Ghe" style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="font-size: 10pt; text-align: left; width: 54%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Preferred Stock</span></td> <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,850,000</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,850,000</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--ConvertiblePromissoryNoteIssuable_uShares_zRGYxfnlzRp" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Promissory Note</span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99,889,073</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,072,770</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zr4hU5NiYOV5" style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,739,073</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,694,114</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 8850000 8850000 99889073 19072770 108739073 36694114 <p id="xdx_800_ecustom--LoansPayableTextBlock_zkKQw6yZwtXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE 4 – <span id="xdx_82C_zjYEfLYO8M47">LOANS PAYABLE</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Promissory Note – Officer</span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through March 31, 2020, John Weber, the Company's Chief Financial Officer, advanced the Company a total of $<span id="xdx_90C_eus-gaap--LoansPayable_iI_c20200331__us-gaap--DebtInstrumentAxis__srt--ChiefFinancialOfficerMember_zBjrGlDjHKO3">335,683</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. On March 31, 2020, these advances were converted into a convertible promissory note. Interest on the note is computed at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_c20230331_zYnTyWkVOSBb">5% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per annum and accrues from the time of the advances until the maturity date. The original maturity date was September 30, 2020, at which time all the accrued interest and principal became due. The note has been extended several times and most recently to <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_c20221001__20221231__us-gaap--DebtInstrumentAxis__srt--ChiefFinancialOfficerMember_zHjAqmeRYHwc">December 31, 2022</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. For the six and three months ended March 31, 2023 and 2022 interest totaling $<span id="xdx_90B_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20221001__20230331__us-gaap--DebtInstrumentAxis__srt--ChiefFinancialOfficerMember_zezFhppE17Wl">9,918</span>, $<span id="xdx_90B_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20211001__20220331__us-gaap--DebtInstrumentAxis__srt--ChiefFinancialOfficerMember_zY0BHybx4ll1">9,132</span>, $<span id="xdx_90A_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20230101__20230331__us-gaap--DebtInstrumentAxis__srt--ChiefFinancialOfficerMember_zhGeXDYRUOZd">4,984</span> and $<span id="xdx_909_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20220101__20220331__us-gaap--DebtInstrumentAxis__srt--ChiefFinancialOfficerMember_zgRZlakSGE05">4,600</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, was incurred. Accrued interest on the note was $<span id="xdx_906_ecustom--AccruedLiabilitiesCurrentRelatedParties_iI_c20230331__us-gaap--DebtInstrumentAxis__srt--ChiefFinancialOfficerMember_zXh2lSA4y8xe">75,389</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> and $<span id="xdx_901_ecustom--AccruedLiabilitiesCurrentRelatedParties_iI_c20220930__us-gaap--DebtInstrumentAxis__srt--ChiefFinancialOfficerMember_z94ZkvnN2b">65,471</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> at March 31, 2023 and September 30, 2022, respectively, which is included in accrued expenses on the accompanying consolidated balance sheets. The note is convertible at the option of Mr. Weber into shares of the Company's common stock at the prevailing market rate on the date of conversion.</span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan Payable:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2011, an investor advanced $10,000. The loan does not bear interest and is due on demand. At both March 31, 2023 and September 30, 2022, the loan payable totaled $<span id="xdx_90C_eus-gaap--LoansPayableCurrent_iI_c20230331_zrxlIXwvwNFe"><span id="xdx_905_eus-gaap--LoansPayableCurrent_iI_c20220930_zNNW5fNNrNpf">10,000</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans Payable - Officer:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through September 30, 2020, J. Roy Nelson, the Company’s Chief Science Officer, made net advances to the Company totaling $<span id="xdx_908_eus-gaap--LoansPayableCurrent_iI_c20200930__us-gaap--DebtInstrumentAxis__custom--ChiefScienceOfficerMember_zBOemteom2bg">26,935</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The loans do not bear interest and are due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2018, Randall McCoy, the Company’s Chief Executive Officer, advanced to the Company $<span id="xdx_909_eus-gaap--LoansPayable_iI_c20180930__us-gaap--DebtInstrumentAxis__srt--ChiefExecutiveOfficerMember_zxOFzt1NMDrk">4,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The loan does not bear interest and is due on demand.</span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From July 2020 through September 2022, John Weber, the Company’s Chief Financial Officer, advanced to the Company $<span id="xdx_90C_ecustom--LoansPayableRelatedParties_c20200701__20220930__us-gaap--ShortTermDebtTypeAxis__srt--ChiefFinancialOfficerMember_zu8GgV3umHC8">90,800</span>. The loan bears interest at <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_c20220930__us-gaap--ShortTermDebtTypeAxis__srt--ChiefFinancialOfficerMember_zRpi8xX6WPy7">5</span>% per annum and is due on demand.</span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 6.6pt 0 0; text-align: justify"/> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 6.6pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 335683 0.05 2022-12-31 9918 9132 4984 4600 75389 65471 10000 10000 26935 4500 90800 5 <p id="xdx_808_eus-gaap--FinancingReceivablesTextBlock_z2PraCMN42M" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE 5 - <span id="xdx_826_zJ4JPHz7iweh">BRIDGE FINANCING</span></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On <span id="xdx_904_eus-gaap--DebtInstrumentIssuanceDate1_c20221001__20230331__custom--NotesPayableAxis__custom--PromissoryNote2Member_zvyOYx04gA5b">December 21, 2011</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, the Company issued a $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20230331__custom--NotesPayableAxis__custom--PromissoryNote2Member_zRzMyD8doyX3">150,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">promissory note to an individual. The note bore interest so that the Company would repay $175,000 on the maturity date of <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230331__custom--NotesPayableAxis__custom--PromissoryNote2Member_z3v7WMNFbhJ">June 21, 2012</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Additional interest of <span id="xdx_909_ecustom--DebtInstrumentAdditionalInterestRateStatedPercentage_iI_c20230331__custom--NotesPayableAxis__custom--PromissoryNote2Member_zZ5VTDftW0F5">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% was charged on any late payments. The note was not paid at the maturity date and the Company is incurring additional interest as described above. At both March 31, 2023 and September 30, 2022, the note balance was $<span id="xdx_90B_ecustom--BalanceOfConvertibleNotesPayable_iI_c20230331__custom--NotesPayableAxis__custom--PromissoryNote2Member_zQzUVRw1rjCi"><span id="xdx_904_ecustom--BalanceOfConvertibleNotesPayable_iI_c20220930__custom--NotesPayableAxis__custom--PromissoryNote2Member_zcp5WI8KgF3g">175,000</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Interest expense was $<span id="xdx_907_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20221001__20230331__custom--NotesPayableAxis__custom--PromissoryNote2Member_zL0g6ZF3raOb"><span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20211001__20220331__custom--NotesPayableAxis__custom--PromissoryNote2Member_zGzn7J0iZq7b">8,726</span></span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for each of the six months ended March 31, 2023 and 2022. Accrued interest on the note was $<span id="xdx_909_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_c20230331__custom--NotesPayableAxis__custom--PromissoryNote2Member_zpF3clubX7kh">186,664 and </span></span>$<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_c20220930__custom--NotesPayableAxis__custom--PromissoryNote2Member_zooeimCpNkia">179,938</span> as of March 31, 2023 and September 30, 2022, respectively, and is included in Accrued expenses - other in the accompanying consolidated balance sheets.</span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2011-12-21 150000 2012-06-21 10 175000 175000 8726 8726 186664 179938 <p id="xdx_804_eus-gaap--InvestmentIncomeTextBlock_zCbKqud4WY6g" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE 6 - <span id="xdx_822_z9y9ktEFLaaj">INVESTMENTS</span></span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such determinations at each consolidated balance sheet date. Debt securities are classified as held-to-maturity when the Company has the positive intent and ability to hold the securities to maturity. Debt securities for which the Company does not have the intent or ability to hold to maturity are classified as available-for-sale. Held-to-maturity securities are recorded as either short term or long term on the consolidated balance sheet, based on contractual maturity date and are stated at amortized cost. Debt securities that are bought and held principally for the purpose of selling them in the near term are classified as trading securities and are reported at fair value, with unrealized gains and losses recognized in earnings. Debt securities not classified as held-to-maturity or as trading are classified as available-for-sale, and are carried at fair value, with the unrealized gains and losses, net of tax, included in the determination of comprehensive income and reported in members’ equity. At March 31, 2023, the Company held an investment in debt securities that was classified as held-to-maturity and consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_zv72ljg5fsv" style="margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - Investment in Debt Securities (Details)"> <tr style="vertical-align: bottom"> <td> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="3" id="xdx_49D_20230331__us-gaap--InvestmentTypeAxis__custom--AmtorizedCostsMember_zGIYNyV9lfDf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amortized<br/> Costs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="3" id="xdx_493_20230331__us-gaap--InvestmentTypeAxis__custom--UnrealizedLossMember_zIX2ZTwvhvsj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Unrealized<br/> Loss</td></tr> <tr id="xdx_40A_eus-gaap--DebtSecurities_iI_zRgfENjMHYSj" style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 53%">United States Treasury Obligation</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 20%">978,860</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 20%">(236</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">)</td></tr> </table> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_zv72ljg5fsv" style="margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - Investment in Debt Securities (Details)"> <tr style="vertical-align: bottom"> <td> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="3" id="xdx_49D_20230331__us-gaap--InvestmentTypeAxis__custom--AmtorizedCostsMember_zGIYNyV9lfDf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amortized<br/> Costs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="3" id="xdx_493_20230331__us-gaap--InvestmentTypeAxis__custom--UnrealizedLossMember_zIX2ZTwvhvsj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Unrealized<br/> Loss</td></tr> <tr id="xdx_40A_eus-gaap--DebtSecurities_iI_zRgfENjMHYSj" style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 53%">United States Treasury Obligation</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 20%">978,860</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 20%">(236</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">)</td></tr> </table> 978860 -236 <p id="xdx_80D_eus-gaap--IncomeTaxDisclosureTextBlock_zHbKvi37aBmg" style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE 7 - <span id="xdx_821_z45qc6ToqVB6">INCOME TAXES</span></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded no income tax expense for the six months ended March 31, 2023 and 2022 because the estimated annual effective tax rate was zero. As of March 31, 2023, the Company continues to provide a valuation allowance against its net deferred tax assets since the Company believes it is more likely than not that its deferred tax assets will not be realized.</span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zAeFrpzez8V2" style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE 8 – <span id="xdx_822_zuWBNfXP08kc">STOCKHOLDERS' DEFICIENCY</span></span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span> </span></span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>Preferred Stock:</span></span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span/></span> </p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series A</span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At both March 31, 2023 and September 30, 2022, <span id="xdx_901_ecustom--SeriesASharesIssued_iI_c20230331_z6p0BCe44Dfc"><span id="xdx_908_ecustom--SeriesASharesIssued_iI_c20220930_zj7ej8dvEPT">885,000</span></span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series A Preferred Stock (“Series A Preferred”) were outstanding.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series A Preferred pays a dividend of <span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentRate_c20221001__20230331_zKe5JDuSfCFl">8% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per annum on the stated value and has a liquidation preference equal to the stated value of the shares ($885,000 liquidation preference as of March 31, 2023 and September 30, 2022 plus dividends in arrears as per below). Each share of Series A Preferred Stock has an initial stated value of $<span id="xdx_901_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pp0d_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zJR3r08WPdSa">1.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and is convertible into shares of the Company’s common stock at the rate of 10 for 1.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series A Preferred Stock was marketed through a private placement memorandum that included a reference to a ratchet provision which would have allowed the holders of the stock to claim a better conversion rate based on other stock transactions conducted by the Company during the three-year period following the original issuance of the shares. The Certificate of Designation does not contain a ratchet provision. Certain of the stock related transactions consummated by the Company during this time period may have triggered this ratchet provision, and thus created a claim by holders of the Series A Preferred Stock who purchased based on this representation for a greater conversion rate than initially provided. There have been no new developments related to the remaining Series A holders regarding this claim and the conversion rate of their Series A Preferred Stock. Changes to the preferred stock conversion ratio may result in modification or extinguishment accounting. That may result in a deemed preferred stock dividend which would reduce net income available to common stockholders in the calculation of earnings per share. Certain of the smaller Series A holders have already converted or provided notice of conversion of their shares. In respect of this claim, the Company and its outside counsel determined that it is not possible to offer an opinion regarding the outcome. An adverse outcome could materially increase the accumulated deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The dividends are cumulative commencing on the issue date when and if declared by the Board of Directors. As of March 31, 2023, and September 30, 2022, dividends in arrears were $<span id="xdx_900_eus-gaap--DividendsPayableCurrent_iI_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zihKFHyd6gUf">835,333 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($.96 per share) and $<span id="xdx_90A_eus-gaap--DividendsPayableCurrent_iI_c20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zZoGXPEs9jj2">818,030 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($.92 per share), respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Four million (<span id="xdx_905_ecustom--SeriesBSharesAuthorized_iI_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zXPWNg8mnCO3">4,000,000) </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series B Convertible Preferred Stock (“Series B Preferred”) have been authorized with a liquidation preference of $<span id="xdx_907_ecustom--DividendStatedValue_c20221001__20230331_zVq6YnsaKIIc">2.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. Each share of Series B Preferred is convertible into ten shares of common stock. Holders of Series B Preferred have a right to a dividend (pro-rata to each holder) based on a percentage of the gross revenue earned by the Company in the United States, if any, and the number of outstanding shares of Series B Preferred, as follows: Year 1 - Total Dividend to all Series B holders = .03 x Gross Revenue in the U.S. Year 2 - Total Dividend to all Series B holders = .02 x Gross Revenue in the U.S. Year 3 - Total Dividend to all Series B holders = .01 x Gross Revenue in the U.S. At March 31, 2023, no shares of Series B Preferred are outstanding. </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 13.45pt 0 0; text-align: justify"/> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 13.45pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 885000 885000 0.08 1.00 835333 818030 4000000 2.00 <p id="xdx_802_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zHNHazSMeqw6" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE 9 - <span id="xdx_826_zeTXA69BJgn6">STOCK-BASED COMPENSATION</span></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance with FASB ASC 505, “Equity.” Costs are measured at the estimated fair value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earlier of a performance commitment or completion of performance by the provider of goods or services as defined by ASC 505.</p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zK89wOduKcD8" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE 10- <span id="xdx_825_zKWMInyvb3Qh">RELATED PARTY TRANSACTIONS</span></span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s principal executive offices are located in Little Falls, New Jersey. The headquarters is located in the offices of McCoy Enterprises LLC, an entity controlled by Mr. McCoy. The office is attached to his residence but has its own entrances, restroom and kitchen facilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also maintains an office at Carbon &amp; Polymer Research Inc. ("CPR") in Pennington, New Jersey, which is the Company's materials and testing laboratory. An officer of the Company is an owner of CPR.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company paid rent in the amount of $<span id="xdx_907_eus-gaap--PaymentsForRent_c20221001__20230331_z9FIoWlicGp7">24,610</span> for the six months ended March 31, 2023. No rent was charged previously.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 16, 2016, the Company entered into an agreement with CPR in which CPR will supply the collagen scaffolds used in the Company's production of the skin tissue. The contract contains a most favored customer clause guaranteeing the Company prices equal or lower than those charged to other customers. The Company has not yet made purchases from CPR.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See Note 4 for loans payable to related parties.</span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 24610 <p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zvSPYrjcn5gf" style="font: 9.5pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE 11 - <span id="xdx_82F_zvYyra8xnSI6">SUBSEQUENT EVENTS</span></span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management has evaluated subsequent events through the date of this filing.</span></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0"/> EXCEL 41 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 42 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 43 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 44 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 85 130 1 false 15 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://RGIN/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://RGIN/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://RGIN/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://RGIN/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Sheet http://RGIN/role/ConsolidatedStatementsOfOperationsParenthetical CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY Sheet http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY Statements 6 false false R7.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://RGIN/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 00000008 - Disclosure - THE COMPANY Sheet http://RGIN/role/Company THE COMPANY Notes 8 false false R9.htm 00000009 - Disclosure - BASIS OF PRESENTATION Sheet http://RGIN/role/BasisOfPresentation BASIS OF PRESENTATION Notes 9 false false R10.htm 00000010 - Disclosure - LOSS PER SHARE Sheet http://RGIN/role/LossPerShare LOSS PER SHARE Notes 10 false false R11.htm 00000011 - Disclosure - LOANS PAYABLE Sheet http://RGIN/role/LoansPayable LOANS PAYABLE Notes 11 false false R12.htm 00000012 - Disclosure - BRIDGE FINANCING Sheet http://RGIN/role/BridgeFinancing BRIDGE FINANCING Notes 12 false false R13.htm 00000013 - Disclosure - INVESTMENTS Sheet http://RGIN/role/Investments INVESTMENTS Notes 13 false false R14.htm 00000014 - Disclosure - INCOME TAXES Sheet http://RGIN/role/IncomeTaxes INCOME TAXES Notes 14 false false R15.htm 00000015 - Disclosure - STOCKHOLDERS' DEFICIENCY Sheet http://RGIN/role/StockholdersDeficiency STOCKHOLDERS' DEFICIENCY Notes 15 false false R16.htm 00000016 - Disclosure - STOCK-BASED COMPENSATION Sheet http://RGIN/role/Stock-basedCompensation STOCK-BASED COMPENSATION Notes 16 false false R17.htm 00000017 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://RGIN/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 17 false false R18.htm 00000018 - Disclosure - SUBSEQUENT EVENTS Sheet http://RGIN/role/SubsequentEvents SUBSEQUENT EVENTS Notes 18 false false R19.htm 00000019 - Disclosure - BASIS OF PRESENTATION (Policies) Sheet http://RGIN/role/BasisOfPresentationPolicies BASIS OF PRESENTATION (Policies) Policies 19 false false R20.htm 00000020 - Disclosure - LOSS PER SHARE (Tables) Sheet http://RGIN/role/LossPerShareTables LOSS PER SHARE (Tables) Tables http://RGIN/role/LossPerShare 20 false false R21.htm 00000021 - Disclosure - INVESTMENTS (Tables) Sheet http://RGIN/role/InvestmentsTables INVESTMENTS (Tables) Tables http://RGIN/role/Investments 21 false false R22.htm 00000022 - Disclosure - THE COMPANY (Details Narrative) Sheet http://RGIN/role/CompanyDetailsNarrative THE COMPANY (Details Narrative) Details http://RGIN/role/Company 22 false false R23.htm 00000023 - Disclosure - Schedule of Income per Common Share (Details) Sheet http://RGIN/role/ScheduleOfIncomePerCommonShareDetails Schedule of Income per Common Share (Details) Details 23 false false R24.htm 00000024 - Disclosure - Income Loss per Common Share Exclusion (Details) Sheet http://RGIN/role/IncomeLossPerCommonShareExclusionDetails Income Loss per Common Share Exclusion (Details) Details 24 false false R25.htm 00000025 - Disclosure - BASIS OF PRESENTATION (Details Narrative) Sheet http://RGIN/role/BasisOfPresentationDetailsNarrative BASIS OF PRESENTATION (Details Narrative) Details http://RGIN/role/BasisOfPresentationPolicies 25 false false R26.htm 00000026 - Disclosure - LOANS PAYABLE (Details Narrative) Sheet http://RGIN/role/LoansPayableDetailsNarrative LOANS PAYABLE (Details Narrative) Details http://RGIN/role/LoansPayable 26 false false R27.htm 00000027 - Disclosure - BRIDGE FINANCING (Details Narrative) Sheet http://RGIN/role/BridgeFinancingDetailsNarrative BRIDGE FINANCING (Details Narrative) Details http://RGIN/role/BridgeFinancing 27 false false R28.htm 00000028 - Disclosure - Investment in Debt Securities (Details) Sheet http://RGIN/role/InvestmentInDebtSecuritiesDetails Investment in Debt Securities (Details) Details 28 false false R29.htm 00000029 - Disclosure - STOCKHOLDERS' DEFICIENCY (Details Narrative) Sheet http://RGIN/role/StockholdersDeficiencyDetailsNarrative STOCKHOLDERS' DEFICIENCY (Details Narrative) Details http://RGIN/role/StockholdersDeficiency 29 false false R30.htm 00000030 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://RGIN/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://RGIN/role/RelatedPartyTransactions 30 false false All Reports Book All Reports [dqc-0015-Negative-Values] Fact us-gaap:InterestIncomeDebtSecuritiesOperating has a value of -850 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:InterestIncomeDebtSecuritiesOperating fact are: Context: From2022-10-01to2023-03-31, Unit: USD, Rule Element Id: 7582. rgin10q.htm 1954 [dqc-0015-Negative-Values] Fact us-gaap:ProceedsFromLimitedPartnershipInvestments has a value of -978010 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:ProceedsFromLimitedPartnershipInvestments fact are: Context: From2022-10-01to2023-03-31, Unit: USD, Rule Element Id: 5932. rgin10q.htm 1989 [dqc-0015-Negative-Values] Fact us-gaap:DebtSecurities has a value of -236 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:DebtSecurities fact are: Context: AsOf2023-03-31_custom_UnrealizedLossMember, Unit: USD, Rule Element Id: 7533. rgin10q.htm 2410 rgin10q.htm ex31_1.htm ex31_2.htm ex32_1.htm rgin-20230331.xsd rgin-20230331_cal.xml rgin-20230331_def.xml rgin-20230331_lab.xml rgin-20230331_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 47 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "rgin10q.htm": { "axisCustom": 1, "axisStandard": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 268, "http://xbrl.sec.gov/dei/2023": 29 }, "contextCount": 85, "dts": { "calculationLink": { "local": [ "rgin-20230331_cal.xml" ] }, "definitionLink": { "local": [ "rgin-20230331_def.xml" ] }, "inline": { "local": [ "rgin10q.htm" ] }, "labelLink": { "local": [ "rgin-20230331_lab.xml" ] }, "presentationLink": { "local": [ "rgin-20230331_pre.xml" ] }, "schema": { "local": [ "rgin-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 225, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 35, "http://xbrl.sec.gov/dei/2023": 5, "total": 40 }, "keyCustom": 15, "keyStandard": 115, "memberCustom": 5, "memberStandard": 9, "nsprefix": "RGIN", "nsuri": "http://RGIN/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://RGIN/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerSharePolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - LOSS PER SHARE", "menuCat": "Notes", "order": "10", "role": "http://RGIN/role/LossPerShare", "shortName": "LOSS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerSharePolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "RGIN:LoansPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - LOANS PAYABLE", "menuCat": "Notes", "order": "11", "role": "http://RGIN/role/LoansPayable", "shortName": "LOANS PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "RGIN:LoansPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - BRIDGE FINANCING", "menuCat": "Notes", "order": "12", "role": "http://RGIN/role/BridgeFinancing", "shortName": "BRIDGE FINANCING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentIncomeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INVESTMENTS", "menuCat": "Notes", "order": "13", "role": "http://RGIN/role/Investments", "shortName": "INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentIncomeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "14", "role": "http://RGIN/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - STOCKHOLDERS' DEFICIENCY", "menuCat": "Notes", "order": "15", "role": "http://RGIN/role/StockholdersDeficiency", "shortName": "STOCKHOLDERS' DEFICIENCY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - STOCK-BASED COMPENSATION", "menuCat": "Notes", "order": "16", "role": "http://RGIN/role/Stock-basedCompensation", "shortName": "STOCK-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "17", "role": "http://RGIN/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "18", "role": "http://RGIN/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - BASIS OF PRESENTATION (Policies)", "menuCat": "Policies", "order": "19", "role": "http://RGIN/role/BasisOfPresentationPolicies", "shortName": "BASIS OF PRESENTATION (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://RGIN/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - LOSS PER SHARE (Tables)", "menuCat": "Tables", "order": "20", "role": "http://RGIN/role/LossPerShareTables", "shortName": "LOSS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentIncomeTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - INVESTMENTS (Tables)", "menuCat": "Tables", "order": "21", "role": "http://RGIN/role/InvestmentsTables", "shortName": "INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentIncomeTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityIncorporationDateOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - THE COMPANY (Details Narrative)", "menuCat": "Details", "order": "22", "role": "http://RGIN/role/CompanyDetailsNarrative", "shortName": "THE COMPANY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityIncorporationDateOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Schedule of Income per Common Share (Details)", "menuCat": "Details", "order": "23", "role": "http://RGIN/role/ScheduleOfIncomePerCommonShareDetails", "shortName": "Schedule of Income per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "RGIN:ConvertiblePreferredStockIssuableUponConversionAndExercise", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Income Loss per Common Share Exclusion (Details)", "menuCat": "Details", "order": "24", "role": "http://RGIN/role/IncomeLossPerCommonShareExclusionDetails", "shortName": "Income Loss per Common Share Exclusion (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "RGIN:ConvertiblePreferredStockIssuableUponConversionAndExercise", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - BASIS OF PRESENTATION (Details Narrative)", "menuCat": "Details", "order": "25", "role": "http://RGIN/role/BasisOfPresentationDetailsNarrative", "shortName": "BASIS OF PRESENTATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2023-03-31_custom_AMBSMember", "decimals": "0", "lang": null, "name": "us-gaap:CommonStockValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "span", "p", "RGIN:LoansPayableTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "Percent", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - LOANS PAYABLE (Details Narrative)", "menuCat": "Details", "order": "26", "role": "http://RGIN/role/LoansPayableDetailsNarrative", "shortName": "LOANS PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "RGIN:LoansPayableTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2022-09-30_srt_ChiefFinancialOfficerMember213607265", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "Percent", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-012023-03-31_custom_PromissoryNote2Member", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentIssuanceDate1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - BRIDGE FINANCING (Details Narrative)", "menuCat": "Details", "order": "27", "role": "http://RGIN/role/BridgeFinancingDetailsNarrative", "shortName": "BRIDGE FINANCING (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-012023-03-31_custom_PromissoryNote2Member", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentIssuanceDate1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock", "us-gaap:InvestmentIncomeTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2023-03-31_custom_AmtorizedCostsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtSecurities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Investment in Debt Securities (Details)", "menuCat": "Details", "order": "28", "role": "http://RGIN/role/InvestmentInDebtSecuritiesDetails", "shortName": "Investment in Debt Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock", "us-gaap:InvestmentIncomeTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2023-03-31_custom_AmtorizedCostsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtSecurities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "RGIN:SeriesASharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - STOCKHOLDERS' DEFICIENCY (Details Narrative)", "menuCat": "Details", "order": "29", "role": "http://RGIN/role/StockholdersDeficiencyDetailsNarrative", "shortName": "STOCKHOLDERS' DEFICIENCY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentRate", "reportCount": 1, "unique": true, "unitRef": "Percent", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "RGIN:AccruedLiabilitiesCurrentRelatedParties", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://RGIN/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "lang": null, "name": "RGIN:SeriesAPreferredStockAtParValue", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForRent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "30", "role": "http://RGIN/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForRent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2023-01-012023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://RGIN/role/ConsolidatedStatementsOfOperations", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2023-01-012023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2023-01-012023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpenseOther", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)", "menuCat": "Statements", "order": "5", "role": "http://RGIN/role/ConsolidatedStatementsOfOperationsParenthetical", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2023-01-012023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpenseOther", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "AsOf2021-09-30_us-gaap_PreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY", "menuCat": "Statements", "order": "6", "role": "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2021-10-012021-12-31_us-gaap_RetainedEarningsMember", "decimals": "0", "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "7", "role": "http://RGIN/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInInterestPayableNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - THE COMPANY", "menuCat": "Notes", "order": "8", "role": "http://RGIN/role/Company", "shortName": "THE COMPANY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - BASIS OF PRESENTATION", "menuCat": "Notes", "order": "9", "role": "http://RGIN/role/BasisOfPresentation", "shortName": "BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rgin10q.htm", "contextRef": "From2022-10-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 15, "tag": { "RGIN_AMBSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "A M B S [Member]" } } }, "localname": "AMBSMember", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "domainItemType" }, "RGIN_AccruedLiabilitiesCurrentRelatedParties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[custom:AccruedLiabilitiesCurrentRelatedParties-0]" } } }, "localname": "AccruedLiabilitiesCurrentRelatedParties", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheetsParenthetical", "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "RGIN_AmtorizedCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amtorized Costs [Member]" } } }, "localname": "AmtorizedCostsMember", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/InvestmentInDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "RGIN_BalanceOfConvertibleNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[custom:BalanceOfConvertibleNotesPayable-0]" } } }, "localname": "BalanceOfConvertibleNotesPayable", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "RGIN_ChiefScienceOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chief Science Officer [Member]" } } }, "localname": "ChiefScienceOfficerMember", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "RGIN_CommonStockReceivable": { "auth_ref": [], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Common stock of Amarantus" } } }, "localname": "CommonStockReceivable", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "RGIN_ConvertiblePreferredStockIssuableUponConversionAndExercise": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Preferred Stock" } } }, "localname": "ConvertiblePreferredStockIssuableUponConversionAndExercise", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/IncomeLossPerCommonShareExclusionDetails" ], "xbrltype": "sharesItemType" }, "RGIN_ConvertiblePromissoryNoteIssuable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note" } } }, "localname": "ConvertiblePromissoryNoteIssuable", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/IncomeLossPerCommonShareExclusionDetails" ], "xbrltype": "sharesItemType" }, "RGIN_DebtInstrumentAdditionalInterestRateStatedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:DebtInstrumentAdditionalInterestRateStatedPercentage-0]" } } }, "localname": "DebtInstrumentAdditionalInterestRateStatedPercentage", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative" ], "xbrltype": "percentItemType" }, "RGIN_DisclosureLoansPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loans Payable" } } }, "localname": "DisclosureLoansPayableAbstract", "nsuri": "http://RGIN/20230331", "xbrltype": "stringItemType" }, "RGIN_DividendStatedValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[custom:DividendStatedValue]" } } }, "localname": "DividendStatedValue", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "RGIN_LoansPayableRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[custom:LoansPayableRelatedParties]" } } }, "localname": "LoansPayableRelatedParties", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "RGIN_LoansPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LOANS PAYABLE" } } }, "localname": "LoansPayableTextBlock", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/LoansPayable" ], "xbrltype": "textBlockItemType" }, "RGIN_NotesPayableAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable [Axis]", "verboseLabel": "NotesPayableAxis [Axis]" } } }, "localname": "NotesPayableAxis", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative" ], "xbrltype": "stringItemType" }, "RGIN_NotesPayableDomain": { "auth_ref": [], "localname": "NotesPayableDomain", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative" ], "xbrltype": "domainItemType" }, "RGIN_OperatingLossBeforeOtherOperatingIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating loss before other operating income" } } }, "localname": "OperatingLossBeforeOtherOperatingIncome", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "RGIN_PromissoryNote2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promissory Note 2 [Member]" } } }, "localname": "PromissoryNote2Member", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative" ], "xbrltype": "domainItemType" }, "RGIN_SeriesAPreferredStockAtParValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SeriesAPreferredStockAtParValue" } } }, "localname": "SeriesAPreferredStockAtParValue", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "RGIN_SeriesAPreferredStockValue": { "auth_ref": [], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Series A 8% Convertible Preferred stock, $0.001 par value, 5,500,000 shares authorized; 885,000 issued and outstanding" } } }, "localname": "SeriesAPreferredStockValue", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "RGIN_SeriesASharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SeriesASharesAuthorized" } } }, "localname": "SeriesASharesAuthorized", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "RGIN_SeriesASharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SeriesASharesIssued", "verboseLabel": "[custom:SeriesASharesIssued-0]" } } }, "localname": "SeriesASharesIssued", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheetsParenthetical", "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "sharesItemType" }, "RGIN_SeriesBSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:SeriesBSharesAuthorized-0]" } } }, "localname": "SeriesBSharesAuthorized", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "sharesItemType" }, "RGIN_UnrealizedLossMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unrealized Loss [Member]" } } }, "localname": "UnrealizedLossMember", "nsuri": "http://RGIN/20230331", "presentation": [ "http://RGIN/role/InvestmentInDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r527", "r529", "r530" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r535" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationDateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when an entity was incorporated", "label": "Entity Incorporation, Date of Incorporation" } } }, "localname": "EntityIncorporationDateOfIncorporation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/CompanyDetailsNarrative" ], "xbrltype": "dateItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://RGIN/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r8", "r504" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses - other (related party of $75,389 and $65,471)" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [ "r80", "r81", "r269", "r270", "r271", "r272", "r273", "r274" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r80", "r81", "r269", "r270", "r271", "r272", "r273", "r274" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r40", "r504", "r583" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r234", "r235", "r236", "r342", "r554", "r555", "r556", "r571", "r585" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/IncomeLossPerCommonShareExclusionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r60", "r74", "r90", "r121", "r127", "r131", "r171", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r252", "r254", "r268", "r319", "r377", "r504", "r515", "r567", "r568", "r574" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total current and total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "BASIS OF PRESENTATION" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r18", "r53", "r88" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "CASH - END OF PERIOD", "periodStartLabel": "CASH - BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r0", "r53" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "NET INCREASE IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r546", "r578" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r69", "r75", "r76", "r77", "r90", "r109", "r110", "r113", "r115", "r119", "r120", "r171", "r184", "r186", "r187", "r188", "r191", "r192", "r211", "r212", "r215", "r218", "r225", "r268", "r332", "r333", "r334", "r335", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r365", "r386", "r407", "r486", "r487", "r488", "r489", "r490", "r537", "r551", "r557" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r505", "r506", "r507", "r509", "r510", "r511", "r512", "r554", "r555", "r571", "r582", "r585" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r39", "r365" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r5", "r39", "r365", "r383", "r585", "r586" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r39", "r320", "r504" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value; 200,000,000 shares authorized; 157,911,410 issued and 153,483,050 outstanding", "verboseLabel": "Common Stock, Value, Issued" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BasisOfPresentationDetailsNarrative", "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r30", "r494" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Interim Financial Statements:" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible promissory note - officer" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentRate": { "auth_ref": [ "r20", "r21" ], "lang": { "en-us": { "role": { "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.", "label": "Debt Conversion, Converted Instrument, Rate" } } }, "localname": "DebtConversionConvertedInstrumentRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r6", "r37", "r38", "r61", "r62", "r92", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r276", "r499", "r500", "r501", "r502", "r503", "r552" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r32", "r34", "r193", "r276", "r500", "r501" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r552" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative", "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r13", "r194" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentIssuanceDate1": { "auth_ref": [ "r7", "r569" ], "lang": { "en-us": { "role": { "documentation": "Date the debt instrument was issued, in YYYY-MM-DD format.", "label": "Debt Instrument, Issuance Date" } } }, "localname": "DebtInstrumentIssuanceDate1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r67", "r499", "r572" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative", "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r14", "r92", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r276", "r499", "r500", "r501", "r502", "r503", "r552" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtSecurities": { "auth_ref": [ "r140", "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading).", "label": "United States Treasury Obligation" } } }, "localname": "DebtSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/InvestmentInDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent": { "auth_ref": [ "r180", "r560" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.", "label": "Investment, at amortized cost" } } }, "localname": "DebtSecuritiesAvailableForSaleAmortizedCostCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": { "auth_ref": [ "r566" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]" } } }, "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesHeldToMaturityNonaccrualInterestIncome": { "auth_ref": [ "r178" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OtherExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income on investment in debt security measured at amortized cost (held-to-maturity), on nonaccrual status.", "label": "Interest income on held-to-maturity investment" } } }, "localname": "DebtSecuritiesHeldToMaturityNonaccrualInterestIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": { "auth_ref": [ "r566" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]" } } }, "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncome": { "auth_ref": [ "r538", "r580", "r581" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred income" } } }, "localname": "DeferredIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r11" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends Payable, Current" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStockCash": { "auth_ref": [ "r1", "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.", "label": "Dividends, Preferred Stock, Cash", "negatedLabel": "Preferred stock dividends" } } }, "localname": "DividendsPreferredStockCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r85", "r98", "r99", "r100", "r101", "r102", "r106", "r109", "r113", "r114", "r115", "r117", "r265", "r266", "r316", "r325", "r495" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Loss per share basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r85", "r98", "r99", "r100", "r101", "r102", "r109", "r113", "r114", "r115", "r117", "r265", "r266", "r316", "r325", "r495" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Loss per share diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r24", "r25" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "LOSS PER SHARE" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/LossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued salaries - officers" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r5", "r70", "r80", "r81", "r82", "r93", "r94", "r95", "r97", "r103", "r105", "r118", "r172", "r173", "r226", "r234", "r235", "r236", "r246", "r247", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r269", "r270", "r271", "r272", "r273", "r274", "r277", "r326", "r327", "r328", "r342", "r407" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Financial Instruments and Fair Value Measurement:" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r174", "r175", "r176", "r177", "r179", "r181", "r182", "r183", "r209", "r223", "r262", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r324", "r498", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r561", "r562", "r563", "r564" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablesTextBlock": { "auth_ref": [ "r136", "r137", "r138", "r139", "r497" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financing receivable.", "label": "BRIDGE FINANCING" } } }, "localname": "FinancingReceivablesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BridgeFinancing" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r50", "r536" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OtherExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Change in unrealized gain (loss) on securities" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r47", "r388" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r91", "r242", "r243", "r244", "r245", "r248", "r249", "r250", "r251", "r337" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r17", "r19" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r3" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r3" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued expenses - other" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedSalaries": { "auth_ref": [ "r3" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in accrued salaries.", "label": "Increase (Decrease) in Accrued Salaries", "verboseLabel": "Accrued salaries - officers" } } }, "localname": "IncreaseDecreaseInAccruedSalaries", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r3" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Accrued interest on loans and notes payable" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapital": { "auth_ref": [ "r3" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.", "label": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r33", "r65", "r83", "r124", "r275", "r392", "r513", "r584" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OtherExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense (related party of $9,918, $9,132, $4,984 and $4,600)" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Interest Expense, Other" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperationsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeDebtSecuritiesOperating": { "auth_ref": [], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income, amortization of premium and accretion of discount, on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading); classified as operating.", "label": "Accretion of discount on held-to-maturity investment" } } }, "localname": "InterestIncomeDebtSecuritiesOperating", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidCapitalized": { "auth_ref": [ "r493", "r550" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidCapitalized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeTextBlock": { "auth_ref": [ "r49", "r51", "r52", "r579" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.", "label": "INVESTMENTS" } } }, "localname": "InvestmentIncomeTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/Investments" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r354", "r355", "r356", "r357", "r358", "r414", "r423", "r436", "r444", "r457", "r461", "r462", "r478", "r482", "r483", "r484", "r485", "r507" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/InvestmentInDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r354", "r355", "r356", "r357", "r358", "r414", "r423", "r436", "r444", "r457", "r461", "r462", "r478", "r482", "r483", "r484", "r485", "r507" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value." } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/InvestmentInDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for cash, cash equivalents, investments in debt and equity instruments (including cost and equity investees and related income statement amounts), equity and cost method investments, investments in joint ventures and any other investment.", "label": "Investment in Debt Securities" } } }, "localname": "InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r44", "r63", "r322", "r504", "r553", "r565", "r573" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' deficiency" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS' DEFICIENCY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r12", "r73", "r90", "r171", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r253", "r254", "r255", "r268", "r504", "r567", "r574", "r575" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LoansPayable": { "auth_ref": [ "r6", "r62", "r577" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Loans Payable [Default Label]", "verboseLabel": "Loans Payable" } } }, "localname": "LoansPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayableCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.", "label": "Loan payable", "verboseLabel": "Loans Payable, Current" } } }, "localname": "LoansPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets", "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r66", "r68" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "THE COMPANY" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/Company" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r87" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r53", "r54", "r55" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r45", "r55", "r64", "r72", "r78", "r79", "r82", "r90", "r96", "r98", "r99", "r100", "r101", "r104", "r105", "r111", "r121", "r126", "r130", "r132", "r171", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r266", "r268", "r323", "r385", "r405", "r406", "r496", "r513", "r567" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "verboseLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows", "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r86", "r98", "r99", "r100", "r101", "r106", "r107", "r112", "r115", "r121", "r126", "r130", "r132", "r496" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net loss attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Pronouncements:" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r10" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Promissory note payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OtherExpenses": { "auth_ref": [ "r48" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense classified as other.", "label": "Other Expenses", "negatedTotalLabel": "Total other expenses" } } }, "localname": "OtherExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expenses)" } } }, "localname": "OtherExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLoansPayable": { "auth_ref": [ "r6", "r62", "r577" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term loans payable classified as other.", "label": "Loans payable - officer" } } }, "localname": "OtherLoansPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncome": { "auth_ref": [ "r46" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.", "label": "Other operating income - reversal of accounts payable" } } }, "localname": "OtherOperatingIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r2" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Payments for Rent" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockConvertibleConversionPrice": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "Per share conversion price of preferred stock.", "label": "Preferred Stock, Convertible, Conversion Price" } } }, "localname": "PreferredStockConvertibleConversionPrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [ "r505", "r506", "r509", "r510", "r511", "r512", "r582", "r585" ], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromLimitedPartnershipInvestments": { "auth_ref": [ "r549" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash inflow received as distributions, returns of capital, or sale proceeds from partnership interests held for investment purposes.", "label": "Proceeds from the sale of partnership interests" } } }, "localname": "ProceedsFromLimitedPartnershipInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Proceeds of loans from officers" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r278", "r279", "r280", "r281", "r282", "r338", "r339", "r340", "r389", "r390", "r391", "r411", "r413" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r35", "r241", "r576" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r41", "r59", "r321", "r329", "r330", "r336", "r366", "r504" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r70", "r93", "r94", "r95", "r97", "r103", "r105", "r172", "r173", "r234", "r235", "r236", "r246", "r247", "r256", "r258", "r259", "r261", "r264", "r326", "r328", "r342", "r585" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r84", "r90", "r122", "r123", "r125", "r128", "r129", "r133", "r134", "r135", "r171", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r268", "r317", "r567" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Income Loss per Common Share Exclusion" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/LossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Income per Common Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/LossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentsLineItems": { "auth_ref": [ "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Investments [Line Items]" } } }, "localname": "ScheduleOfInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/InvestmentInDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsTable": { "auth_ref": [ "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r463", "r464", "r465", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investments owned by investment company.", "label": "Schedule of Investments [Table]" } } }, "localname": "ScheduleOfInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/InvestmentInDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r547", "r548", "r570" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r547", "r548", "r570" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r237", "r238", "r239", "r240" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "STOCK-BASED COMPENSATION" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/Stock-basedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Shares, Outstanding, Ending Balance", "periodStartLabel": "Shares, Outstanding, Beginning Balance" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/LoansPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r69", "r75", "r76", "r77", "r90", "r109", "r110", "r113", "r115", "r119", "r120", "r171", "r184", "r186", "r187", "r188", "r191", "r192", "r211", "r212", "r215", "r218", "r225", "r268", "r332", "r333", "r334", "r335", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r365", "r386", "r407", "r486", "r487", "r488", "r489", "r490", "r537", "r551", "r557" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r5", "r16", "r70", "r80", "r81", "r82", "r93", "r94", "r95", "r97", "r103", "r105", "r118", "r172", "r173", "r226", "r234", "r235", "r236", "r246", "r247", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r269", "r270", "r271", "r272", "r273", "r274", "r277", "r326", "r327", "r328", "r342", "r407" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://RGIN/role/StockholdersDeficiencyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r93", "r94", "r95", "r118", "r315", "r331", "r353", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r387", "r388", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r407", "r508" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative", "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r93", "r94", "r95", "r118", "r315", "r331", "r353", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r387", "r388", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r407", "r508" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BridgeFinancingDetailsNarrative", "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r5", "r16", "r59" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ScheduleOfIncomePerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r39", "r42", "r43", "r57", "r367", "r383", "r408", "r409", "r504", "r515", "r553", "r565", "r573", "r585" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' DEFICIENCY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r28", "r29", "r31", "r70", "r71", "r81", "r93", "r94", "r95", "r97", "r103", "r172", "r173", "r226", "r234", "r235", "r236", "r246", "r247", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r269", "r270", "r274", "r277", "r327", "r328", "r341", "r367", "r383", "r408", "r409", "r491", "r514", "r553", "r565", "r573", "r585" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total stockholders' deficiency" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r58", "r89", "r210", "r212", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r224", "r226", "r263", "r410", "r412", "r492" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Equity [Text Block]", "verboseLabel": "STOCKHOLDERS' DEFICIENCY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/StockholdersDeficiency" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r283", "r284" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Going Concern:" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r209", "r223", "r262", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r324", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r561", "r562", "r563", "r564" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r15", "r26", "r27" ], "calculation": { "http://RGIN/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Less: treasury stock; 4,428,360 shares at par" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r4" ], "calculation": { "http://RGIN/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "negatedLabel": "Unrealized loss on investment" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/BasisOfPresentationDetailsNarrative", "http://RGIN/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r108", "r115" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average number of shares outstanding diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": { "auth_ref": [ "r22", "r23" ], "lang": { "en-us": { "role": { "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).", "label": "Weighted average number of shares outstanding basic" } } }, "localname": "WeightedAverageNumberOfSharesIssuedBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://RGIN/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//310-10/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-44", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org//310-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.C.Q3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org//205-40/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4,6)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r516": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r517": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r518": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r519": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r521": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r522": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r523": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r524": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r525": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r526": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r527": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r528": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r529": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r531": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r532": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r533": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r534": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r535": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481174/470-10-25-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.B)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 48 0001662252-23-000017-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001662252-23-000017-xbrl.zip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